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Hemicelluloses constitute a significant part of plant biomass, yet so far it has
been difficult to make use of this class of polysaccharides. A lack of access
to this class of molecules prevents the use of enzymatic studies to increase
our understanding of the biochemical processes relevant to the synthesis and
degradation of hemicellulose. In this thesis the synthesis of arabinoxylans as well
as glucuronoxylans is demonstrated. At first, a reliable strategy to efficiently
synthesize a variety of xylan backbones was established. Two strategies were
tried. The first strategy was an attempt to use an unprotected xylose acceptor
ii
in a tin-mediated glycosylation. Since the best results of the optimization of
this reaction were not good enough a second strategy was pursued. This second
strategy is based on the preactivation of thioglycosides to be glycosylated with
thioglycoside acceptors which in turn can be preactivated again in a second
step. Optimization of this strategy lead to a viable pathway towards a variety of
protected xylan backbones. The use of protecting groups allows for the specific
introduction of branching units to the backbone. Subsequently arabinose as well
as glucuronic acid were attached to the xylan backbone.
Summary (Danish)
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Hemicellulose udgør en væsentlig del af plantebiomasse, men alligevel har det
været vanskeligt at få adgang til denne klasse af polysaccharider. En manglende
adgang til denne klasse af molekyler forhindrer enzymatiske undersøgelser der
vil kunne øge vores forståelse af de biokemiske processer relevant for syntese og
nedbrydning af hemicellulose. I denne afhandling er syntesen af arabinoxylaner
samt glucuronoxylaner demonstreret. Der blev etableret en strategi for en pålidelig
og effektiv syntese af en række xylan skeletter. To strategier blev forsøgt. Første
strategi var et forsøg på at bruge en ubeskyttet xylose acceptor i en tin-medieret
iv
glycosylering. De bedste resultater under optimeringen af denne strategi var ikke
gode nok og derfor blev en ny strategi forsøgt. Strategi nummer to blev baseret på
præaktivering af et thioglycosid der senere hen glycosyleres med en thioglycosid
acceptor som igen kan præaktiveres i et efterfølgende trin. Optimering af denne
strategi førte til en brugbar metode og førte til en række af forskellige beskyttede
xylan skeletter. Anvendelsen af beskyttelsesgrupper introducerer en specifik
forgrening af enheder til skelettet og medførte efterfølgende at arabinose samt
glucuronsyre blev bundet til et xylan skelet.
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Chapter 1
Introduction
2 Introduction
1.1 The Cell Wall
In 1804, the Royal Society of Science in Göttingen (Königliche Societät der
Wissenschaften) publicly issued a competition to answer the question of how
plant cells are built. Of special interest at that time has been the question
of whether plant cells have individual walls or whether there is only one wall
encompassing all cells. The question was answered by Friedrich Heinrich Link in
Rostock and simultaneously by Karl Asmund Rudolphi in Greifswalde. In 1807,
Link published their findings in a text book on plant anatomy and physiology
(Figure 1.1).1
Figure 1.1: Microscopy sketch by Link of Lyfimachia thyrfiflora, clearly showing
the cell walls.1
Since then, many details about the cell wall’s structure, composition and
function have been discovered. Nowadays, it is generally divided into two parts:
primary and secondary cell wall. The primary cell wall is recognized as a thin
and pliant structure, that allows for the growth of the cell. The mature plant
then develops a secondary cell wall, which is thicker, stronger and more rigid
to provide stability.2 Keegstra notes in his review on plant cell walls that this
1.1 The Cell Wall 3
division applies to two extreme states, since all cells have their own distinct,
specialized cell walls.3 Chemically, cell walls are comprised of a host of different
macromolecules - proteins, lignin and polysaccharides.
The fact that most proteins in the cell wall are glycosylated and that the cell
wall consists mostly of polysaccharides as well as the difficulty of eliminating
contaminations, has hampered the process of identifying cell wall proteins to a
great extent. Nonetheless, it is known that there are many proteins involved
in the building and modification of the cell wall and cell signaling, often times
related to defense and (a)biotic stress.4 They also enable plants to be strong as
well as flexible.2
Lignin is a phenolic polymer that gives plants mechanical support to stand
upright and to enable the xylem to withstand the negative pressure, allowing for
water transportation. Lignin-deficient mutants have shown diminished growth
and sometimes dwarfing, indicating the importance of lignin in stabilizing the
xylem.5
The best known cell wall polysaccharide is cellulose, which is an integral part of
every plant’s cell wall. After synthesis in the cytosol and transport through the
membrane, cellulose chains form crystalline microfibrils via hydrogen bonding,
thereby contributing to the cell’s rigidity.6
Pectin constitutes the second class of polysaccharides of the cell wall. Pectin
contains several different polysaccharide domains that are covalently connected
with each other. The main pectic polysaccharides are homogalacturonan, xylo-
galacturonan, apiogalacturonan, rhamnogalacturonan I and rhamnogalacturonan
II.7 Pectin contributes to a plant’s strength as well as flexibility, and forms part
of a barrier against pathogens. Additionally, it has been shown that pectin
fragments interact with kinases that are involved in stress and pathogen response
pathways.8 This allows plants to react accordingly to damage and attacks.
Pectin is synthesized in the Golgi in its methylated form and de-esterified upon
relase into the cell wall.8
The third class of polysaccharides are hemicelluloses. First described in 1891 by
Ernst Schulze9 as “those components of the cell wall that are easily soluble in hot,
diluted mineral acids“,10 the term has undergone a change in meaning. Hemicel-
luloses are nowadays defined as a group of polysaccharides, characterized by
being neither cellulose nor pectin and by having β-(1→4)-linked backbones of glu-
cose, mannose or xylose.11 This class will be further discussed in the next section.
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The plant cell wall is a highly sophisticated system of macromolecules that fulfills
a multitude of functions, necessary for a plant’s life. Models of the structure and
composition of this essential cell component have been growing more complicated
over the years (Figure 1.2).
Figure 1.2: A modern depiction of cell wall composition, preserving the relative
size of the different layers as well as abundance and localization of
the various components12
An increase in knowledge has led to an increase in application. The abundance
of plants makes their utilization attractive. While many applications have been
found in the energy sector,13 food14 and materials15,16 there remains room
for improvement. Pentoses, for example, are not fermented by yeast and are
therefore inaccessible to normal ethanol production.17 Since pentose containing
hemicelluloses account for up to 50% of the biomass of annual and perennial
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plants,18 a lot of material goes unutilized. Isolation as well as application of non-
cellulosic cell wall components remain challenging. An increased understanding
of the biosynthesis and degradation of these compounds, would allow scientists
to make better use of this abundant and renewable resource.
6 Introduction
1.2 Hemicelluloses
According to the previously mentioned definition, hemicelluloses are a group
of polysaccharides having β-(1→4)-linked backbones of glucose, mannose or
xylose.11 From this definition, there emerge three distinct classes, two of which
have their own subclasses:
Mannans mannans, galactomannan, glucomannan and galactoglucomannan
Xyloglucans This class has been found to be sometimes covalently linked to
pectin and non-covalently binding to cellulose19–21
Xylans glucuronoxylans (GX), glucuronoarabinoxylan (GAX), arabinoxylans
(AX)
Among the various hemicelluloses, xylans are the most common, constituting
the second most abundant biopolymer in the plant kingdom.22 All classes have
been found to be acetylated to some degree in their native state.22 Additionally,
ferulic and coumaric esters can be formed linking the hemicellulose to lignin.11
Generally, hemicelluloses contribute to the strength of the cell walls and are
of special relevance in secondary cell walls. This often puts them in second
place after cellulose in plant biomass. Xylans have been shown to be critical
in the growth of some plants, thereby indicating a potentially important role
in stabilizing the vessel walls necessary to transport water. The vessel walls
need to be strong enough to withstand the high negative pressure generated by
transpirational pull.14
In seeds, hemicelluloses can function as storage carbohydrates, analogous to
starch.11 This has been shown to be the case for xylans in the endosperm of
cereal grains.
Hemicelluloses are able to bind to cellulose microfibrils within the cell wall
(Figure 1.2).22 Apart from its stabilizing properties, arabinoxylan has been
shown to inhibit ice formation and might contribute to the survival of plants
during winter.23
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Hemicelluloses occur in many varieties depending on the plant and the part of the
plant examined. This abundance makes them attractive targets for utilization,
for example in the food industry influencing the quality of cereal flours and
dough or as a starting material for xylitol, a popular sugar substitute.24
Another major target application can be found in the conversion of biomass
to bioethanol. First generation biofuels are produced through fermentation of
glucose derived from starch. One of the main disadvantages consists in the
competition of food-crops with fuel-crops. To circumvent this problem, second
generation biofuels are currently being developed where glucose is obtained
from cellulose.13 The aim here is to utilize the non-food plant biomass, which
consists mainly of lignocellulosic material. Potential resources could be the
pulp and paper industry, various crops, straw and grass.18 The difficulty of
this approach lies in the inherent stability of lignocellulosic biomass. Lignin is
cross linked with cellulose and hemicellulose. Additionally, a large percentage of
hemicellulose consists of xylose and other pentoses, which are currently difficult
to ferment. This creates a need for the development of processes that can extract
the fermentable sugars as well as increasing the amount of fermentable sugars
and to apply these processes to all parts of a plant.13
One component in this development might be the genetic modification of plants,
which in turn would ease the efforts of extraction and conversion of useful
components. Potential approaches would target a decrease of the acetate content
which inhibits the fermentation by yeast or a modification of the ferulate esters
to reduce the attachment to lignin.17
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1.3 Xylans
1.3.1 Structure
Arabinoxylans consist of a β-(1→4) connected xylopyranose backbone with L-
arabinofuranose substituted on the 2-and/or 3-positions (Figure 1.3). At least
in grasses, the O-3 position of the xylose residue seems to be generally prefered
for Araf substitution.11
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Figure 1.3: Chemical structure of L-arabino-D-xylan
Additionally, it has been found that in grasses, the 5-position of arabinose is
substituted with ferulic acid, linking it to lignin.17,24
In glucuronoxylans glucuronic acid is typically α-(1→2)-linked to the xylan
backbone. Often times, the glucuronic acid is methylated on the 4-position
(Figure 1.4). According to a 2012 study, this might enhance the overall stability
of the cell wall and an artificial decrease in O-4 methylation leads to to an
increased release of glucuronoxylan upon mild hydrothermal pretreatment.25
Some xylans have be shown to contain arabinose as well as glucuronic acid - so
called glucuronoarabinoxylans (GAX).
.
.
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Figure 1.4: Chemical structure of Glucuronoxylan
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In 1971, xylan hydrate has been found to form twisted ribbon-like strands
with three-fold symmetry winding around a column of water which differs from
mannan and cellulose chains that have been found to form untwisted, ribbon-like
structures with a two-fold symmetry. Addition of L-arabinose units do not
change the basic conformation of the xylan structure (Figure 1.5).26,27
Figure 1.5: Projections perpendicular (top) and parallel (bottom) of (a) xy-
lan backbone, (b) backbone and one L-arabinose side group; (c)
backbone and two L-arabinose side groups. Hydrogen bonds are
shown dotted. In each case the backbone is a left-handed three-fold
helix.27,28
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1.3.2 Biosynthesis
An overview of the biosynthesis of xylans and other hemicelluloses has been most
recently given by Pauly et al. in 201314 as well as Rennie and Scheller in 2014.17
Unlike for mannans and xyloglucans, no cellulose-synthase-like (CSL) genes
have been identified in the backbone synthesis of xylans. Instead, a variety of
glycosyltransferases (GTs) of the GT43 family have been found to be involved in
this process: IRX9, IRX14, IRX10 in Arabidopsis. These GTs are named after
irregular xylem phenotypes of their corresponding mutants, affected by dwarfism.
It has been observed that abundance and length of xylans in these mutants is
reduced. Similar genes have been identified in poplar.
Glycosidic linkages are made by GTs utilizing activated donors (usually the
UDP or GDP derivatives, but also nucleotide mono phosphates, lipid phosphates
and unsubsituted phosphates).29 In the case of the xylan biosynthesis, the
UDP-derivatives have been identified as the enzyme substrates:
O
O
OH
HO
HO
P
O
O-
O P
O
O-
O O
OHOH
N
NH
O
O
Figure 1.6: UDP-Xylose is used as the the substrate for glycosyltransferases
in the xylan synthesis.
UDP-Xyl is generated through a transformation of UDP-GlcA inside and outside
of the Golgi. Depending on whether the glycosidic linkage is formed via retention
or inversion of the stereocenter compared to the donor, GTs can be classified
as either inverting or retaining. The GT43 family contains only the inverting
kind.30 The mechanism usually involves activation of the phosphate through
chelation by some metal ion and subsequent SN2 substitution on the anomeric
center.29
One lesser understood phenomenon is the tetrasaccharide unit Xyl-Rha-GalA-
Xyl at the reducing end of xylans in Arabidopsis. It has been shown that this
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tetrasaccharide plays a very important role in the xylan biosynthesis, although
it is not clear how. Two hypotheses have been proposed:14
1. The tetrasaccharide might act as a primer from which the xylan synthesis
begins by elongation at the non-reducing end.
2. The tetrasaccharide might act as a terminator of the xylan chain after a
certain length has been reached.
Interestingly, this tetrasaccharide has not been found to occur in grasses and
alternative explanations of how the xylan backbone is synthesized in those cases
are still lacking. What seems to be clear so far is that several GTs from the
GT61 family as well as other enzymes are needed to work interdependently in a
xylan synthase complex to synthesize the xylan backbone.14
According to Pauly,14 there exists a better understanding of the substitution
of xylans. For the attachment of GlcA and Araf to the xylan backbone, var-
ious genes have already been identified in Arabidopsis as well as wheat and
rice. Glucuronic acid has been found to be added to the xylan backbone by
glucuronosyltransferases (GUX). It has also been found that the arabinofuranose
substituents are generated through a series of transformations from UDP-Xyl
to UDP-Arap to UDP-Araf by an epimerase and mutase respectively outside
of the Golgi and then somehow transported into the Golgi. Some progress has
also been made on identifying the enzymes responsible for the modification
of xylans, for instance the O-4 methylation of glucuronic acid residues by GX
methyltransferase (GXMT/GMX3) using S-adenosylmethionine or the O2- and
O3-acetylation of xylans with AcCoA. During the course of that research it
has also been shown that these modifications are essential for the function of
xylans. Rennie and Scheller have provided a graphical overview of the curent
understanding of the xylan synthesis in the Golgi apparatus:17
12 Introduction
Figure 1.7: An overview of the Xylan biosynthesis in the Golgi apparatus,
adapted from Rennie and Scheller.17
1.3.3 Degradation
On the quest to independence from fossil fuels and petrochemistry, considerable
effort is being made to derive energy and valuable chemicals from biomass. The
obvious advantage would be the ability to escape the limited supply of oil by
using a sustainable process of growth, harvest and recycling while at the same
time producing less waste and polution.31
Essential steps towards realizing this vision consist of understanding, modifying
and utilizing the natural degradation processes of plant ploysaccharides into
their monosaccharide untis. The natural processes leading to the degradation of
plant material are highly efficient, but slow.32
Hydrolysis of hemicellulose has been shown to be complicated by the fact
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that a number of different enzymes are necessary to degrade it. For example,
debranching without depolymerization of the backbone has been shown to
lead to intermolecular aggregation leading to precipitation which makes further
depolymerization impossible.33–36 The best way to handle this problem has been
found to be the use of different enzymes simultanously.37–40
The two main groups of hemicellulose degrading enzymes can be divided into main-
chain enzymes and side-chain enzymes. The main-chain enzymes include β-1,4-
D-xylanases and xylosidases. Side-chain enzymes include α-arabinofuranosidases,
acetyl xylan esterases and α-D-glucuronidases (Figure 1.8).33,41
Figure 1.8: Schematic representation of enzymes involved in the hydrolysis of
a substituted xylan42
The degradation of linkages between carbohydrates and lignin is facilitated by
enzymes such as acetyl xylan esterase, ferulic acid esterase and p-coumaric
esterases which attack the hemicellulose side chains and break any bonds to
lignin.43 The delignification process still needs to be optimized and a better
understanding of all the enzymes involved is necessary.
Xylanases
The best studied xylanases belong to gylcosyl hydrolase (GH) families 10 and
11.44 In order for these enzymes to cleave the 1,4-β-D-xylosidic linkages it is
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required for the backbone to have at least three consecutive, unsubstituted xylose
units. That makes these enzymes unsuitable for the degradation of more densely
substituted xylans. A more suitable enzyme has recently been discovered. This
arabinoxylanase from the GH5 family has an extra binding pocket to accomodate
an arabinose unit close to the cleave site.45 Other examples of xylanases accomo-
dating substituents close to the active site are GH30 glucuronoxylanses.46,47 This
is significant in light of findings that have shown some xylanses to be inhibited
by the presence of glucuronoxylanases.48,49 GH30 glucuronoxylanases have been
shown to cleave glucuronoxylans by binding 4-OMe-GlcA or unmodified GlcA
substituents at the -2 subsite.50
Accessory Xylanolytic Enzymes
Those enzymes that remove the main chain substituents in xylans are called
accessory xylanolytic enzymes. They can be divided into two groups:51
• Enzymes that remove side chains only from short branched oligosaccharides
generated by endoxylanases
• Enzymes that remove side chains from both, polymeric and oligomeric
substrates
It has been shown that GH67 α-glucuronidases act synergistically with xylanases
to liberate MeGlcA from glucuronoxylans.52,53 The synergistic effect has been
demonstrated repeatedly. After the xylanase degrades the backbone, the glu-
curonidase acts on short oligosaccharide fragments to release those MeGlcA
residues that are connected to the non-reducing terminal end of the xylan
chain.54,55
A more recently discovered class of α-glucuronidases is GH115.56–58 This class
differs from GH67 in that it is able to release MeGlcA linked to internal as well as
non-reducing terminal xylopyranosyl residues. A recent study has demonstrated
that GH115 enzymes act as inverting glycoside hydrolases, releasing MeGlcA
as its β-anomer.51 It has also been shown that substrates can have different
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lengths from two to five xylose units. An increase in length led to an increase of
substrate specificity indicating that the enzyme binds to the MeGlcA residue
and two adjacent xylopyranosyl residues.51
Among arabinofuranosidases four enzyme families have been identified so far.
An extensive overview is given by Lagaert:59
• GH43: Some enzymes in this family have been found to cleave arabinose
at the O-3 position from xyloses with substitutions at the O-2 as well
as the O-3 position.60–64 Others exclusively hydrolyze arabinose linkages
from xyloses that have only one arabinose residue linked to either the O-2
or O-3 position.60,65 The two types can work in synergy when the first
one removes the arabinose on the O-3 position, making more substrate
available for the second kind.60,62,66
• GH51: Except for four endoglucanases, this family contains only arabinofu-
ranosidases and contains the largest number of studied arabinofuranosidases.
Most of the arabinofuranosidases have wide substrate specificity and are
able to cleave arabinose from longer as well as shorter chains. Most en-
zymes show a preference towards cleaving either from the O-2 or O-3
position and studies have shown that the active site contains only enough
room for monosubstituted xyloses.62,67 Nevertheless, small activity towards
disubstituted xyloses has been observed as well.68,69
• GH54: Most enzymes found in this family show selective activity towards
arabinose bound to the O-3 position on singly substituted xylose residues
at the non-reducing end of arabinoxylan oligosaccharides. Acitivity towards
the middle xylose in xylotriose has been much reduced or absent.70–72
• GH62: This family contains exclusively arabinofuranosidases and all en-
zymes release arabinose from arabinoxylans.68,73–77 Until now three en-
zymes have been studied and all have shown to cleave arabinose from a
monosubstituted xylose and never from a disubstituted moiety. Two of the
enzymes showed a preference towards cleaving from the O-3 position over
against the O-2 position.68,75
The continued study of hemicellulose degrading enzymes will be much aided by
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a higher availability of pure, well-defined oligosaccharides. This is especially the
case for the study of those enzymes that depend on the prior cleavage of the
substrate into smaller units. Currently this availability is relatively low and most
studies rely on impure polysaccharides and their mixed degradation products.
Chemical synthesis of relevant enzyme substrates can therefore prove to be very
valuable to the biological and biochemical community in this area of modern
research.
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1.4 Chemical Synthesis of Oligosaccharides
The most exhaustive overview on carbohydrate chemistry in general and oligosac-
charide synthesis in particular can be found in Fraser-Reid’s 3000 page refer-
ence work Glycoscience.78 Additionally Demchenko’s Handbook of Glycosylation
Chemistry gives a detailed overview over all modern glycosylation methods.79
The synthesis of oligosaccharides is marked by a constant focus on chemoselec-
tivity, stereoselectivity and reactivity. Two factors are especially characteristic
of oligosaccharide synthesis:
1. On the one hand, the multitude of similar functional groups make it difficult
to connect two carbohydrate molecules in a specific way.
2. On the other hand, reactivity between different carbohydrates can differ in
unexpected ways, often times necessitating a lot of trouble shooting and
adjustments in one’s chosen synthetic strategy.
Despite these difficulties, modern chemical synthetic methods are capable of
overcoming most of these problems, given enough time and resources. A multitude
of protecting groups can be used today to overcome the problem of the similarity
of functional groups. The problem of reactivity has been and still is being
addressed by the introduction of a variety of glycosylation methods of which one
can usually expect at least some to work well for a particular problem. In addition
to these advances, we have today a better understanding of the relationship
between utilized protecting groups and reactivity as well as chemoselectivity
than ever before. A short survey of the most successful strategies to overcome
the typical problems shall be outlined here.
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1.4.1 Mechanistic Considerations
The Glycosyl Cation
In order for a new glycosidic bond to be formed, the old one needs to be broken.
The question that has prompted intense investigations concerns the mechanism
of the bond breaking. Is there a glycosyl cation? If so, does it exist as a contact
ion pair or a solvent separated ion pair? Does the glycosylation reaction follow a
SN1 or SN2 pathway? How much do protecting groups and solvent influence the
answers to these questions? A review by Bohe and Crich in 2014 gives an overview
of the research done on this topic.80 In general the question of whether a SN1 or
SN2 pathway is followed needs to be answered for every individual reaction and
many times an in-between mechanism is assumed.81 A number of computational
and indirect methods have been employed, trying to prove the existence of the
glycosyl cation. Bohe and Crich concluded that the evidence points towards the
existence of these cations in some cases. Very recently, glycosyl cations have
been directly observed in low temperature NMR experiments.82 The cations
were formed by adding different sugar derivatives to a solution of HF/SbF5.
In this superacidic83 medium all acetate protecting groups are protonated and
the anomeric acetate reacts further to give the corresponding glycosyl cation
(Figure 1.9).
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Figure 1.9: In a superacidic solution the glycosyl cation obtained from per-
acetylated 2-deoxyglucose is stable and observable by NMR at
-40°C.82
The experiment was conducted with peracetylated 2-deoxyglucose as well as with
2-bromoglucose. In both cases the cation has been observed. The NMR data
showed a 1H-NMR shift for the anomeric proton of the 2-deoxy sugar at 8.89
ppm and a 13C-NMR shift of 229.1 ppm. The 2-bromo derivative has a 1H-NMR
1.4 Chemical Synthesis of Oligosaccharides 19
shift at 8.36 ppm and a 13C-NMR shift of 198.1 ppm. The chemical shifts and
coupling constants in combination with calculations showed that the 2-deoxy
derivative assumes a 4E conformation whereas the 2-bromo derivative assumes
a 4H 5 conformation in which the bromine coordinates towards the anomeric
carbon. This difference in conformation led to a difference in products when
both cations were deuterated. Deuteration with cyclohexane-d12 84,85 led to the
formation of mostly the deuterated α-product for the 2-deoxy sugar and mostly
the β-product for the 2-bromo sugar. Both results are in accordance with the
presumed conformations.
The Anomeric Effect
Any glycosylation reaction can in theory have two stereochemical outcomes.
Typically, the glycosyl donor needs to be activated by a promoter. Activation
leads to the formation of a glycosyl oxocarbenium ion,82 which can then be
attacked from either side by an acceptor. The product can be the α- or the
β-anomer (Figure 1.10).
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Figure 1.10: The two possible stereochemical outcomes of a glycosylation,
exemplified on a glucose derivative.
It has been observed that glycosylation reactions under thermodynamic condi-
tions generally lead to the α-anomer.86 Two different explanations have been
given for that phenomenon. The first one is based on favourable dipole-dipole in-
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teractions for the alpha anomer, while the second one proposes that the α-anomer
is stabilized by the n(O)→σ∗(C-X) orbital interaction. The debate surrounding
which explanation would be the correct one is ongoing. An argument in favour
of the electrostatic model has been made in 2010 based on calculations.87 Often
times it is argued that α-selectivities in modern glycosylation methods are due
to the anomeric effect. Ian Cumpstey refuted this idea in 2012, arguing that
the anomeric effect can not account for selectivities in glycosylation reactions
under kinetic control. It is rather the structure of the individual substrate, the
particular reaction conditions and ultimately the transition state energies that
determine the stereoselectivities.81
Participating Protecting Groups
The most frequently employed tool to perform glycosylations with high stereose-
lectivities is the use of ester protecting groups on C-2. This was described by
Lemieux in 1954.88 Participation of these groups during glycosylation reactions
leads to a blocking of the anomeric center from the side of the protecting group,
forcing the acceptor to attack from the other end (Figure 1.11). This leads
usually to the exclusive formation of 1,2-trans-glycosides. The same study that
proved the existence of glycosyl cations mentioned above, managed to also prove
the existence of the dioxazolinium cation by NMR.82
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Figure 1.11: A carbonyl-containing protecting group on the 2-position can
participate in the reaction by blocking the anomeric center from
one side, thereby leaving the incoming acceptor with the only
option to attack from the opposite side.
Armed/Disarmed Effect
In order to connect two carbohydrates in a specific way, the most common
method is to block all functional groups except for the one that is desired to be
connected. In carbohydrate chemistry, protecting groups play more roles than
just blocking off reactive functional groups. They have been found to be crucial
in tuning chemoselectivity as well as stereoselectivity of glycosylation reactions.
An exhaustive overview of this topic can be found in Fraser-Reid’s 2011 book
Reactivity Tuning in Oligosaccharide Synthesis.89 An overview over the most
common protecting groups and their usage can be gained from the chapter on
protecting groups in Comprehensive Glycoscience.90
The phenomenon of the armed/disarmed effect describes the correlation between
certain kinds of protecting groups on a glycosyl donor and its reactivity. This
has been mentioned by Paulsen in 198291 and formalized and given its name
by Fraser-Reid in 1988.92–94 Donors containing ester groups are generally less
reactive than those containing ether groups since the electron withdrawing effect
of the ester carbonyl destabilizes the potential glycosyl cation. This insight
allows one to adjust the reactivity of the donor depending on the individual
problem. These reactivity differences have been famously exploited by Wong’s
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research group when they synthesized a library of 50 different thioglycosides
to construct a relative reactivity scale.95–97 This reactivity scale allowed them
to perform computer optimized one-pot procedures toward oligosaccharides in
which the thioglycosides would be activated one after another according to their
reactivity (Figure 1.12).
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Figure 1.12: One-pot synthesis of a tetrasaccharide based on the reactiv-
ity differences between donors and acceptors, depending on the
armed/disarmed effect.95
In more recent years the concept of super-armed and super-disarmed donors
has been introduced by Bols et al.98,99 Unlike the previous donors, these donors
derive their reactivity not from their electronic but from their steric properties.
A detailed account of the development of this field can be found in Reactivity
Tuning in Oligosaccharide Synthesis 89 and specifically in a whole chapter on the
topic of superarmed and superdisarmed donors.94
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1.4.2 Glycosidic Bond Formation
Glycosidic bond formations generally proceed according to the same general
principle. The heteroatom attached to the anomeric center undergoes electrophilic
attack which leads to the formation of a glycosyl cation which in turn is able
to react with the glycosyl acceptor. Depending on the circumstances of the
reaction the solvent, protecting groups and the overall electronic structure of the
molecule, intermediates undergo more or less something between an SN1 and
SN2 reaction.
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Figure 1.13: General principle of glycosidic bond formation
Fischer Glycosylation
Emil Fischer was the first to describe the general principle of glycosylating
alcohols with sugars in 1893.100 He showed that in principle any alcohol can
react with any sugar when dissolved in a solution of hydrochloric acid in the
respective alcohol to form the corresponding glycoside.
ROH,
HCl
+
O
(HO)3
OH
OH
O
(HO)3
OH
OR
ORO
HOHO
(OH)2
Figure 1.14: Under Fischer glycosylation conditions, one can get either the
furanose or pyranose form, and either the alpha or beta mixture.
Because of the nature of the chemical equilibrium, over time the
most stable product will be dominant in the reaction mixture.
This method is still used today for the synthesis of simple aliphatic glycosides.
Its disadvantages are the formation of several byproducts and harsh reaction
conditions. A modern improvement has been found by Izumi et al. in 2002.101
They describe a procedure in which hydrochloric acid is generated in situ by
using TMSCl at room temperature. This allows for the formation of propargyl
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glycosides, which cannot be formed under standard Fischer conditions due to
polymerization.
Koenigs-Knorr Glycosylation
A major milestone in glycosylation reactions has been the development of glycosyl
bromides by Wilhelm Koenigs and Eduard Knorr in 1901.102 Glycosyl bromides
were originally synthesized from fully acetylated carbohydrates. The glycosyl
bromides were then activated through silver carbonate, allowing for an attack
of a nucleophile to perform the glycosylation. Later developments showed that
this procedure can also be applied to glycosyl chlorides and iodides.103 Helferich
popularized the use of mercury salts as activating agents104 and a variety of
silver and mercury salts have been used.105 Hydrolysis can be easily prevented
by using molecular sieves. An alternative way of synthesizing the glycosyl halides
is to generate them from thioglycosides.106,107 Variations of the Koenigs-Knorr
method have been the main backbone of oligosaccharide synthesis until the
development of more advanced methods in the 1970s and 1980s.108–110 The
most prominent development has been the introduction of glycosyl fluorides.111
Their high stability led to a neglect by the scientific community until it was
discovered that they can be activated by many promoter systems, for example
SnCl2-AgClO4.112 The high stability, ease of synthesis and a mild promoter
system makes glycosyl fluorides a useful tool in oligosaccharide synthesis.113
Thioglycosides as Donors
Thioglycosides were first synthesized by Fischer and Delbrück in 1909.114 They
observed that these compounds are significantly more stable towards hydrolysis
than their oxygen counterparts. Bamford et al. did kinetic studies to analyse
the mechanism of the hydrolysis, but did not attempt to utilize them in any
synthetically useful way.115
Thioglycosides were publicly presented as a new donor class in 1973 by Ferrier
et al. in an article with the prescient title A Potentially Versatile Synthesis of
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Glycosides.116 This class would indeed become one of, if not the most versatile
one. Ferrier et al. used phenyl thioglycosides as donors and mercury salts as
activating agents for glycosylation reactions.
While Fischer originally prepared his thioglycosides by treating the peracety-
lated glycosyl bromide with the thiol and sodium hydroxide,114 nowadays thio-
glycosides are most commonly prepared by treating peracetylated carbohy-
drates with the thiol under Lewis-acidic conditions117 as has been originally
established by Lemieux in 1951.118 The most popular Lewis-acids for this
purpose are BF3·Et2O119–123 and SnCl4,124 although many more have been
described.117,119,125,126
One of the strengths of this donor class is, that it can be converted into any of
the other donors (Figure 1.15). This is an advantage, if it turns out that the
thioglycoside is not able to perform the desired glycosylation. The treatment with
molecular bromine has been described already in 1958 by Weygand.127 Alterna-
tively iodonium bromide can be used as well.128 Glycosyl fluorides are accessible
via NBS activation and reaction with DAST.129 Access to trichloroacetimidates
is available indirectly through simple hydrolysis with NBS in aqueous acetone
and similar systems.130,131 Glycosyl sulfoxides can be obtained by oxidation
with mCPBA.132,133
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Figure 1.15: Thioglycosides can be converted into any of the other major donor
classes.117
As mentioned before, since 1977 thioglycosides have been primarily used not as
a bridge towards a variety of glycosyl donors (although a useful property), but
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as a donor itself. Ferrier initially used mercury(II)acetate as a promotor. Other
heavy metal salts have been used, but generally gave poor yields, which hindered
the general adoption of these donors. In 1985 Hans Lönn showed that methyl
triflate can act as a promoter.125,134 The yields achieved with this method were
generally good and heavy metals could be avoided altogether. The disadvantage
of using methyl triflate lies in its high toxicity which is caused by its extremely
strong ability to methylate. This ability can also lead to methylation of the
acceptor.117
Nowadays there are a lot of options for activation, which have better properties.
DMTST as a promoter was described by Fügedi and Garegg a year later.135 It’s
less reactive, but still quite sensitive to moisture and requires careful storage under
dry, cold conditions. Some of the more popular choices today are NIS/TfOH
or NIS/TfOTMS,136 BSP/Tf2O,137 diphenylsulfoxide/Tf2O,138 phenylsulfenyl
chloride/AgOTf139 and its derivative p-NO2PhSCl/AgOTf.140 The respective
advantages and disadvantages usually relate to the temperature at which the
donor can be activated as well as the stability of the promoter. For example,
NIS is usually used at around -30°C, wheras phenylsulfenyl chloride activates
donors at -78°C. On the other hand phenylsulfenyl chloride is not shelf-stable,
but it’s 4-nitro derivative is stable over several weeks when stored at 4°C. A
recent review lists 66 different promoter systems.141
The reactivity of thioglycosides can partly be tuned by chosing the substitutent
on the sulfur. A study by Oscarson and Lahmann showed that the reactivity
is dependent on the ability of the substituent to withdraw or donate electron
density.142 Since activation proceeds via electrophilic activation one would expect
electron withdrawing substituents to reduce the reactivity whereas electron
donating substitutents to increase it. This is in accordance with what has been
observed.142 The reactivity scale established in that study is as follows:
tBu > cHex > Hex > iPr > Et > Me > Tol > Ph
Halide substituted phenyl groups have been found to be inert under the reaction
with DMTST, but could be activated with NIS/AgOTf. These differences though
are not enough to activate a donor in the presence of an acceptor differing only
in the sulfur substitutent.142
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Another aspect of thioglycoside chemistry is the possibility to preactivate them
in the absence of an acceptor.143 By first generating a glycosyl triflate, which
can be stabilized at low temperatures, one can ensure full activation of a donor
before adding another thioglycoside as an acceptor. This has been exploited in
sequential one-pot procedures.144–148 For example, in 2013 Gao and Guo pre-
sented their synthesis of a heptasaccharide lipomannan in which a major building
block was synthesized in a one-pot fashion based on a pre-activation procedure
(Figure 1.16).148 The obtained tetrasaccharide was afterwards transformed into
a glycosyl acetimidate to be coupled to another trisaccharide.
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Figure 1.16: One-pot sequential glycosylation towards a tetrasaccharide in
which the donor was preactivated with p-TolSCl before addition
of the acceptor. The product of the coupling could in turn be
activated and coupled in the same way until the tetramer was
reached in an overall yield of 39%.148
A review by Cai et al. in 2014 gives an overview of how sulfenyl triflates have
been used to generate glycosyl triflates and summarizes mechanistic studies on
the topic.149
The first observation of glycosyl triflates by NMR has been made by Crich
and Sun in 1997.150 They generated the triflates by treating the corresponding
28 Introduction
glycosyl sulfoxides with triflic anhydride at -78°C. Among other things they
found out that the sulfenyl triflate is so reactive that it immediately generates
the glycosyl triflate and cannot be detected by itself by NMR (Figure 1.17). They
have also studied the stability and selectivity of glycosyl triflates, finding that
the results can vary depending on the protecting groups and solvent employed.
(Decomposition has been detected between -30°C and -10°C.) Likewise, the
efficiency of the glycosylation is still dependent on the individual properties of
the donor. Huang et al. found that unreactive donors can be tuned towards giving
better glycosylation yields by introducing arming protecting do not groups.151
Contrary to their expectations the arming protecting groups do not facilitate
the activation step. Instead the glycosylation step by itself is facilitated.151
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Figure 1.17: The generation of glycosyl triflates from phenylsulfenyl triflates
has been found to be so fast that the phenylsulfenyl triflate can
only be detected by NMR when generated in the absence of a
glycosyl donor.150
In 1998 Crich et al. reported the application of their insights to a β-mannosylation
protocol.152 They generated a mannosyl triflate by treating a mannosylsulfoxide
with triflic anhydride at -78°C. The generation of the α-triflate enabled them to
perform several β-mannosylations with high selectivities.152
The most important side reaction for thioglycosides is the aglycon transfer. It
is possible for acceptors to transfer their thio-aglycon to the donor instead of
attacking with their free hydroxyl group. This depends on the reaction conditions
and can in part be mitigated by using sterically more hindered thiols.153–155
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Figure 1.18: Aglycon transfer is a typical side reaction for thioglycoside accep-
tors. One way to mitigate it is the introduction of more sterically
hindered substituents on sulfur.154
Acetimidates as Donors
Acetimidates as glycosyl donors were first reported by Pougny et al. in 1977.156
They reported that glycosyl chlorides can be converted to the corresponding imi-
date by reaction with silver oxide, base and N -methylacetamide. The activation
of those imidates was accomplished using PTSA and di- as well as trisaccha-
rides were synthesized in high yields. In 1980 Schmidt and Michel built on
those results by introducing glycosyl trichloroacetimidates and aryl substituted
acetimidates.157 Different from the previous methods, these imidates were not
synthesized from glycosyl halides, but from the hemiacetals, circumventing the
need for activation with heavy metals (Figure 1.19).
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Figure 1.19: Synthesis of trichloroacetimidates can be accomplished starting
from the hemiacetal. The base can influence the stereoselectivity
of the reaction. The imidate is typically activated with either
TMSOTf or BF3·Et2O. Typical bases are: DBU, Cs2CO3, K2CO3,
NaH
The trichloroacetimidates could be activated with catalytic amounts of boron
trifluoride giving the glycosylation products in good yields and good stereos-
electivities. The imidates having an α-configuration led consistently to the
β-product, independent of the presence of participating groups. The advantages
of this method compared to the old one were easier preparation as well as higher
reactivity of the imidates.158 Since then the method has been applied to a wide
variety of problems, especially glycoconjugate synthesis.159–163
Although trichloroacetimidates work well in many reactions, there are cases
in which glycosylations have been unsuccesful.164 To solve this problem N -
phenyltrifluoroacetimidates have been found to provide a solution in many cases.
Their synthesis is just as easy (Figure 1.20).
Trifluoroacetimidates have again been first synthesized by Schmidt et al. in
1984.165 Because of their lower reactivity they have not been studied further
until 2001 when Tao and Yu reported the synthesis and application of the N -
phenyl derivative.166 They showed how these donors can be used to synthesize
oligosaccharides and saponins. They are generally more stable which might help
with certain generally unstable donors and has been an advantage in solid-phase
synthesis of oligosaccharides.167 Unlike its predecessor, the formation of this donor
is irreversible leading to a mixture of anomers and allowing for the preparation of
ketosyl donors.168–170 Another area in which the N -phenyltrifluoroacetimidates
have an advantage is the glycosylation with amides and hydroxamic acids in
which the leaving group becomes a competitor with the amide that is to be
coupled.171
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Figure 1.20: The N -phenyltrifluoroacetimidoyl chloride is commercially avail-
able and can be synthesized in a one-pot reaction combining amide
formation and an Appel reaction.172,173 The glycosyl imidate is
formed analagous to the trichloroacetimidate.
An example of a successful oligosaccharide synthesis based on the acetimidate
method is the synthesis of glycoconjugate vaccines by Wu and Bundle in 2005
(Figure 1.21).174 To reach an oligomannan target they coupled an acetimidate
donor to a mannose acceptor. The non-reducing end of the disaccharide was
then deprotected at the 2-position and through oxidation and stereoselective
reduction the glucose unit was transformed into a new mannose acceptor which
in turn could be coupled with an acetimidate donor again. This circumvents
the need for a reliable β-mannosylation method by relying on the participating
group of the glucose donor. Repeating this procedure another time accomplished
the synthesis of the β-(1→4)-linked tetramannan using only acetimidates in the
glycosylation step.
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Figure 1.21: Synthesis of a tetramannan by Wu and Bundle174
1.4.3 Synthesis of Xylans
Xylans can be extracted from plant material. The disadvantage is that only
inseparable mixtures can be isolated.175,176 For example a recent publication de-
scribes the isolation of "well-defined" oligosaccharides by hydrolysis of beechwood
xylans with sulfuric acid.177 Nevertheless, what was obtained were mixtures of
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oligosaccharides of different lengths. Generally, isolation of hemicellulose frag-
ments requires careful hydrolysis and chromatography and often time delivers
only small quantities of material.178–183 This complicates the analysis of enzyme
activity and selectivity and so far only chemical synthesis is able to deliver pure,
well-defined substrates in higher quantities.
Xylobiose was first synthesized in 1961 by coupling a peracetylated xylopyranosyl
bromide donor with a 1,2,3-benzylated xylopyranose acceptor promoted by
Hg(CN)2.184 Over the next decade, some improvements have been made.185
Longer β-(1→4)-linked xylan chains of three to four, five and six units have
been synthesized in the early 1980s in a series of publications based on the
same Koenigs-Knorr coupling conditions reported by Kovac et al.186–188 The
couplings have been performed towards the direction of the non-reducing end
of the chain by debenzylating the 4-position of the oligosaccharides. At the
same time some effort has been made to synthesize branched oligoxylans and
glucuronoxylans.189,190 The glucuronic acid has been introduced by using the
glucuronyl chloride as a donor and silver perchlorate as a promoter to give a
separable α/β-mixture (2.7 : 1). Oscarson and Svahnberg synthesized small
glucuronoxylan fragments based on xylobiose in 2001 (Figure 1.22).191 Using
DMTST in diethyl ether they were able to couple the glucuronic acid donor with
complete α-selectivity to the disaccharide acceptor.
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Figure 1.22: Synthesis of a small glucuronoxylan fragment by Oscarson and
Svahnberg191research
In the 1990s, Takeo et al. synthesized a series of oligoxylans of up to four
units based on a combination of the Koenigs-Knorr conditions and thioglyco-
side chemistry, connecting two disaccharides to give a tetrasaccharide.192 They
have afterwards improved their blockwise approach and were able to synthesize
oligosaccharides containing ten units of xylose.193,194 In 2002 Chen and Kong
reported the synthesis of a β-(1→3)-linked xylohexaose, extending the chain
in the direction of the reducing end with a disaccharide building block using
acetimidate chemistry.195 Arabinoxylans have recently been synthesized via
solid-phase synthesis by Schmidt et al.196 Using the automated oligosaccharide
synthesizer developed by the group of Peter Seeberger197 they were able to
synthesize β-(1→4)-linked xylan chains up to the octasaccharide and several
shorter arabinoxylan chains carrying up to two arabinose units at the 3-position.
1.4 Chemical Synthesis of Oligosaccharides 35
Figure 1.23: Solid phase automated synthesis of some arabinoxylans as de-
scribed by Seeberger et al.196
This was made possible by attaching a xylopyranosyl phosphate to a linker
attached to the solid phase. By removing the Fmoc protecting group from the
4-position, another unit of a xylopyranosyl phosphate can be added through a TM-
SOTf promoted glycosylation. The introduction of arabinose to the 3-positions
was made possible by selectively introducing benzyl and naphthyl protecting
groups. After selective deprotection, the arabinofuranosyl thioglycoside was
coupled to the backbone via NIS/TfOH.
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1.5 Goal
In order to be able to better study the functions and selectivities of hemicellulose
degrading enzymes, the need for higher quantities of a variety of pure, well-
defined oligosaccharide substrates needs to be fulfilled. The goal of this project
is to develop a reliable synthetic strategy that allows for the construction of
various arabinoxylan and glucuronoxylan fragments. The strategy will focus on
building up the xylan backbone first. The use of protecting group chemistry will
then allow for selective deprotection of either only the O-3 position or the O-2
and O-3 position of selected xylose units in order to attach the desired arabinose
or glucuronic acid donors in one glycosylation step to the backbone.
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Figure 1.24: General strategy to arrive at arabinoxylan and glucuronoxylan
fragments; P = different protecting groups
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2.1 Glycosylation with an Unprotected Acceptor
Based on previous work by Agnese Maggi198 in which a protocol for a regioselec-
tive glycosylation with unprotected acceptors based on stannylene acetals has
been established, we tried to extend the scope of the reaction towards xylose.
This method has so far been only applied to aldohexoses and provided exclusive
selectivity for the 6-position.
Retrosynthetically, the problem can be divided into the glycosylation of a
perbenzoylated glycosyl bromide and an unprotected thioglycoside (Figure 2.1.
There exists literature precedent that xylose can be monoalkylated via tin
chemistry on the 4-position.199
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Figure 2.1: Retrosynthetic strategy: Starting from the fully protected bromide
and the unprotected thioglycoside, tin-mediated glycosylation leads
to the desired 1→4 glycosidic bond. The remaining hydroxyl groups
are protected and the thiophenyl group substituted to give the
bromide which can undergo the same tin-mediated glycosylation
as before.
For that purpose the respective thiophenyl xylose acceptor 1 and xylose donor 2
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have been synthesized as shown in Scheme 2.1. Xylose is fully acetylated and
the thiophenyl group is introduced by the help of a Lewis acid. Deacetylation
leads to acceptor 1. The donor 2 can be obtained by fully benzoylating xylose
and treating the product with HBr.
O
OH
HO
HO SPh
1. Ac2O, Et3N,
DMAP, CH2Cl2
2. PhSH,
BF3•Et2O,
CH2Cl2
3. NaOMe,
MeOH
Xylose
1. BzCl, Pyr
2. HBr, C2H4Cl2
Xylose
35% over 3 steps
O
BzO
BzO
BzO Br
1
2
Scheme 2.1: Synthesis of the fully unprotected thioxyloside and perbenzoylated
xylosyl bromide.
Using the exact same reaction conditions as in the previously established protocol
leads to a significant number of unidentified side products. To establish the
viability of this reaction, a screening of solvents without any preceding tin acetal
formation has been done.
The solvents tested were DMF, DME, DCM, Toluene, MeCN and diethyl ether.
Under all conditions yields were low and the formation of a number of side
products could be observed by TLC. Generally, the most prevalent product was
the trisaccharide 3. The highest yield for this has been obtained using DME
as the solvent (Scheme 2.2). The structure of 3 was determined by NMR. An
HMBC experiment shows the attachment of both xylose units to the 2- and
3-positions while the 4-position showed no long-range coupling to either unit.
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Scheme 2.2: Reaction between the fully unprotected thioxyloside and fully
benzoylated xylosyl bromide
Using MeCN, the reaction was slowed down considerably, allowing for the
isolation of less than 10% of the undesired regioisomer 4 and the desired one 5.
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Scheme 2.3: The coupling between acceptor 1 and donor 2 in MeCN leads to
the formation of small quantities of the two regiosomeric disac-
charides 4 and 5
In one instance during the screening process, small quantities of the aglycon
transfer product 6 have been isolated. This explains the overall poor yields and
high amount of side products since this aglycon transfer leads to the formation
of the reactive glycosyl cation 7 which is able to react with itself (Scheme 2.4).
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Scheme 2.4: Aglycon transfer leads to formation of highly reactive glycosyl
cation 7 which in turn is able to react with itself. The agly-
contransfer product 6 has been identified via NMR with the
orthothioester signal showing at 110.0 ppm.
Since DME as solvent leads to the cleanest reaction with the highest yield, it
was chosen as the solvent for coupling the tin acetal of 1 with donor 2. It
was found that slowly adding the donor to a solution of the tin acetal leads
to a cleaner reaction. Additionally, forming the tin acetal in DME instead of
methanol likewise leads to better results. Adding 1 equivalent of the donor 2
to the solution via a syringe pump over 5 hours resulted in 22% yield of the
product 8 (Scheme 2.5).
O
OH
HO
HO SPh +
O
BzO
BzO
BzO Br
1. Bu2SnO, DME
2. AgOTf, DME
22 %
O
O
BzO
BzO
O
OH
HO
O SPh
O
Ph
- 30°C
70°C
1
2
8
Scheme 2.5: Optimized reaction conditions lead to formation of orthoester 8.
NMR analysis showed the orthoester signal at 121.6 ppm as well
as long-range coupling with the H-4 of the unprotected unit in an
HMBC experiment.
This time the main product is the correct regioisomer and could presumably be
easily transfomed into the desired disaccharide. Nevertheless, the low yield and
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continuous formation of side products indicate that the aglycon transfer cannot
be stopped even at lower temperatures.
Considering these results, the synthetic approach needed to be changed.
2.2 Preactivation based glycosylation strategy
The second strategy is based on work by Huang et al.145 They describe an
optimized one-pot strategy in which thioglycosides are preactivated with p-
tolylsulfenyl chloride and silver triflate to be reacted with another thioglycoside
acceptor, which in turn is available for a new round of activation right after the
coupling. In this way they were able to build a tetrasaccharide in a fairly short
amount of time in 55% yield (Figure 2.2).
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Figure 2.2: One-pot synthesis by Huang et al.145
The adapted retrosynthetic strategy is depicted in Figure 2.3. This time, the
donor is a thioglycoside which can be preactivated. After the activation step a
suitably protected acceptor can be added to give the corresponding disaccharide.
This disaccharide contains a thiophenyl group at the non-reducing end which
can be activated again to be available for another round of glycosylation. This
process can then be repeated until the desired chain length is obtained.
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Figure 2.3: Retrosynthetic strategy: A thioglycoside donor is preactivated
and subsequently coupled to another thioglycoside acceptor. The
new disaccharide contains the thiophenyl group at the reducing
end, allowing for another sequence of preactivation and coupling.
This process is repeated until the desired length of the backbone
is reached. The choice of protecting groups allows for a partial
deprotection of the backbone so as to enable a selective introduction
of the branching units to the xylan backbone.
Applying this strategy to the present problem of synthesizing xylans, acceptor
and donor were synthesized according to Scheme 2.6. The donor can be obtained
by synthesizing triol 1 as described previously and then fully benzoylating it.
Synthesis of acceptor 11 is based on a strategy by Yang et al. who worked with
p-tolyl thioxylosides.200
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Scheme 2.6: Synthesis of donor 9 and acceptor 11.
To arrive at the acceptor, the unprotected thioglycoside 1 is first partially pro-
tected via acetalization of the 2- and 3-position. This is the most difficult step,
mainly because the regioisomers are difficult to separate. The acetal can be
formed between the 2- and 3-position or between the 3- and 4-position. Addi-
tionally the former regioisomer has been found to undergo further acetalization
on the four position with another unit of 2-methoxypropene. Once the desired
acetal is isolated, protection of the 4-position with PMB-Cl, cleavage of the
acetal, benzoylation of the 2- and 3 positions followed by cleaving the PMB-ether
leads to acceptor 11.
Since the promoter is not commercially available due to its instability, it needs
to be freshly synthesized according to Scheme 2.7. Thiophenol is reacted with
sulfuryl chloride under inert conditions and the sulfenyl chloride subsequently
distilled off the reaction mixture under reduced pressure according to a procedure
found in a patent.201
SH SO2Cl2, Et3N
Hexane, Ar
S Cl
84 %
12
Scheme 2.7: Synthesis of activating reagent phenylsulfenyl chloride.201
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Applying the same reaction conditions as described by Huang,145 disaccharide
13 was isolated in 64% yield:
i) AgOTf (2 eq), PhSCl
ii)
64 %
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Scheme 2.8: Synthesis of disaccharide 13 employing Huang’s reaction condi-
tion.145
The one-pot protocol towards the synthesis of the trisaccharide 14 leads to
mostly disaccharide 13 and a smaller amount of trisaccharide 14.
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Scheme 2.9: One-pot synthesis of trisaccharide 14 leads to the trisaccharide as
the minor product next to the disaccharide as the major product.
To investigate whether this can be improved by using a different promoter
system a series of experiments has been conducted, testing Me2S2/Tf2O,202
1-benzenesulfinyl piperidine/Tf2O203 and p-nitrobenzenesulfenyl chlo-
ride/AgOTf.140 The former two systems led to a number of unidentified side
products, and only small amounts of the product as assessed by TLC. Only
the last system led to a clean conversion and satisfactory yields of the desired
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product, surpassing even phenylsulfenyl chloride. With the nitro derivative,
the disaccharide could be isolated in 79% yield and the trisaccharide could be
isolated in 69% yield after a one-pot procedure if a slight excess of the promoter
is used (Scheme 2.10). As has been described by Crich et al.,140 1.2 equivalents
of the promoter gave the highest yields.
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Scheme 2.10: Using p-NO2PhSCl as a promoter, the disaccharide can be
obtained in 79% yield. The trisaccharide is obtained in 69%
yield when the preactivation strategy is applied as a one-pot
procedure.
2.2.1 Synthesis of Selectively Protected Acceptors
Encouraged by the previous results, the next step was to find a suitable acceptor
containing two different protecting groups so that one arabinose unit can be
attached selectively to the xylan chain. According to a procedure by Hung,147
persilylated phenyl thioxyloside 1 should be selectively benzylated on the 3-
position. A subsequent ytterbium triflate catalyzed benzoylation was reported
to be selective at the 2-position. Unfortunately those results could not be
reproduced and only traces of the 3-benzylated product 16 could be isolated
next to the 29% of the 4-benzylated product 17 (Scheme 2.11).
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Scheme 2.11: The selective benzylation protocol by Hung147 could not be
reproduced and led to the wrong regioisomer in low yield.
Since the selective benzylation did not work as expected, different conditions
for a selective benzoylation have been tried. Reacting compound 10 with one
equivalent of benzoyl chloride in pyridine is slow (12h) and leads to mostly the
dibenzoylated product. Benzoylation with silver oxide is likewise similarly slow
and leads roughly to a 1:1 ratio between the two possible regioisomers and also
some amount of the dibenzoylated product, as could be seen on the TLC. The
best way to selectively benzoylate the 2-position is to employ a phase-transfer
catalyst. This reaction proceeds to completion within 30-60 minutes, gives high
selectivity and a high yield (Scheme 2.12).
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Scheme 2.12: Regioselective benzoylation using a phase transfer catalyst leads
to compound 18 as the major product.
Due to the presence of sulfur, a later deprotection of benzyl groups might be
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impossible, even after removal of the thiophenyl group. Therefore only esters
were considered as the second protecting group for the acceptor. This has the
added benefit of being able to attach it on the 2-position as well, thereby keeping
the neighboring-group participation. The introduction of the chloroacetyl group
is simple and causes no problems. Subsequent deprotection with DDQ leads to
acceptor 22:
Pyr
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18 21 22
Scheme 2.13: Protection with chloroacetyl.
Using the previously established reaction conditions for the glycosylation yields
only 42% of disaccharide 23 (Scheme 2.14).
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Scheme 2.14: Glycosylation with chloroacetyl protected acceptor 22
The main reason for this low yield is most likely the lower stability of the
chloroacetyl group in the presence of the silver salt.
The second ester protecting group that has been tried is the levulinic ester and
the synthesis is just as straight-forward as the introduction of the chloroacetyl
group. Thioglycoside 18 is esterified using levulinic acid and DCC/DMAP to
give the ester 24 in 98% yield. Subsequent deprotection of the PMB ether gives
the acceptor 25 in 83% yield (Scheme 2.15).
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Scheme 2.15: Synthesis of acceptors 25 and 27.
Acceptor 25 yielded much better results in the glycosylation, giving disaccharide
28 in 60% yield (Scheme 2.16).
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Scheme 2.16: Glycosylation with Lev-group containing acceptor 25
To test how the deprotection conditions might affect the oligosaccharide, disac-
charide 28 was treated with hydrazine. After 20 minutes the starting material
was fully consumed. After washing, the deprotected disaccharide 29 was obtained
in 90% yield.
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Scheme 2.17: Deprotection of the levulinic ester via hydrazine
Interestingly, the coupling constant of the anomeric proton at the non-reducing
end of disaccharides 13 and 28 are relatively low between 4.8 and 4.7 Hz. Lower
coupling constants are usually an indication for α-anomers. There are several
reasons to assume that in this case the structures are β-anomers with unusual
conformations leading to lower tetrahedral angles between the H-1 and H-2
protons which result in lower coupling constants:
• The removal of the Lev group results in a significantly higher coupling
constant of 6.9 Hz in compound 29.
• The CH coupling constants are 184 Hz in both cases, indicating a β
configuration.204
• Extension of the chain leads to higher coupling constants in the subsequent
units of between 6 and 7 Hz.
• There’s no mixture of anomers and the participating effect of the O-2
benzoyl group would strongly favour the β anomer (see section 1.4.1).
The last building block in the pentaxylan precursor of the glucuronoxylan
contains a benzyl group at the reducing end. This can be easily synthesized
from compound 20 by glycosylation with NIS/TfOH and benzyl alcohol. The
reaction is fast and after an extended reaction time, the acid labile PMB group
is removed as well, giving acceptor 30 in 65% yield (Scheme 2.18).
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Scheme 2.18: Synthesis of acceptor 30 by glycosylation with NIS/TfOH and
benzyl alcohol.
2.2.2 Optimizing Reaction Conditions
While repeating the glycosylation reaction it was observed that the yield suddenly
dropped by about of 20%. A change in the colour of the commercially available
promoter 4-nitrophenylsulfenyl chloride prompted to suspect a change in purity.
Repeated attempts to recrystallize the compound failed. Sublimation turned
out to be a much better way to purify the compound and to the best of my
knowledge has not been reported before. The freshly purified compound exhibits
a bright yellow colour and has a melting point between 47°C and 51°C whereas
the commercially available technical grade product looks light brown and melts
at 43°C. The purification did not change anything with regards to the lower
yield, but allowed for ensuring a constantly good quality reagent that can now
be used with 1 equivalent, instead of the 1.2 equivalents of the commercially
available product. The purified compound was stored under argon in the fridge
and was found to be working well even after a month of storage.
After excluding impurities and moisture in the reaction as causes for the drop in
yield the only variable left was the temperature. To understand the influence of
the temperature on the reaction, a special Schlenk flask with a second neck was
used to measure the exact temperature of the reaction mixture at every point
in time during the reaction. The activation of the donor is quick and goes to
completion within 5-10 minutes even at -78°C. It was found that when adding
the acceptor at temperatures lower than -60°C the aglycon transfer becomes
increasingly dominant leading to the regeneration of the donor 9. This can
be observed via TLC and around 10% of the donor have been isolated after
column chromatography. Under those conditions the disaccharides 13 and 28
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were isolated in 54% and 44% yield respectively. While it is advantageous to keep
the temperature as low as possible during the activation to ensure the stability
of the intermediate triflate, it is necessary to get the temperature higher than
-60°C to make sure the acceptor reacts with the donor in the desired way. After
several trials to examine the influence of the temperature on the reaction, the
optimum reaction temperature seems to be around -55°C for the first 15 minutes
(Scheme 2.19). Under these conditions yields close to 90% can be easily achieved
irrespective of whether acceptor 11 or 25 is used.
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Scheme 2.19: Influence of the reaction temperature on the yield.
2.2.3 Synthesis of Oligoxylans
Next, the new reaction conditions were tested as a one-pot procedure with
acceptors 25 and 11. Under these conditions only 28% of the trisaccharide 31
could be isolated Scheme 2.20. Running the same reaction with the addition
of TTBP205 to mitigate the possible influence of the increasing amount of acid
lowered the yield even more to 17%, while 80% of acceptor 11 were isolated.
The TLC showed a complex mixture of other products.
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Scheme 2.20: One-pot procedure applied to two different acceptors.
In an attempt to allow for a more convergent synthetic pathway, it was considered
that using donor 20 might allow for using disaccharide 32 as a precursor to
a disaccharide donor by deprotecting the PMB group after the coupling. The
coupling with acceptor 25 resulted in a yield of 30%. The PMB group is not stable
enough under the glycosylation conditions which then leads to a competition
between acceptor 25 and the deprotected derivative of disaccharide 32. This
was confirmed when the thioether 33 was found. Its NMR spectrum matched a
reference in the literature.206
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Scheme 2.21: Disaccharide synthesis with PMB-donor
Because neither the one-pot strategy nor the convergent approach seemed viable
without a major time investment in optimization, trisaccharide 31 was synthe-
sized in a separate step after previously isolated disaccharide 28 was coupled
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with acceptor 25 in 69% yield. Another round of preactivation and glycosylation
of this trisaccharide with acceptor 25 yields tetrasaccharide 34 in 67% yield
(Scheme 2.22). If acceptor 11 is used, tetrasaccharide 35 is obtained in 50%
yield. Although less fast than the one-pot procedure, the glycosylation products
once isolated can be immediately used as donors in the next glycosylation step
without any further modification, thereby still saving time over approaches that
do not depend on the preactivation principle.
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Scheme 2.22: Synthesis of tetrasaccharides 34 and 35 after isolation of the
trisaccharide 31.
In the same way, tetrasaccharide 37 can be obtained by first synthesizing
trisaccharide 36 in 88% yield, followed by glycosylation with acceptor 25 to
afford compound 37 in 69% yield (Scheme 2.23).
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Scheme 2.23: Synthesis of tetrasaccharide 37 after isolation of the trisaccharide
36.
The partial deprotection of the tetrasaccharide can be easily performed with
hydrazine in acetic acid and pyridine leading to triol 38 in 97% yield. The
purification consists of simply washing the reaction mixture.
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Scheme 2.24: Removal of the levulinic esters on tetrasaccharide 37
Likewise, pentasaccharide 42 has been synthesized stepwise with good to moder-
ate yields, using acceptor 27 in the first step to synthesize the disaccharide 39,
followed by three glycosylation steps using acceptor 11 (Scheme 2.25).
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Scheme 2.25: Stepwise synthesis of pentaxylan 42 has been accomplished
in moderate to good yields using the optimized glycosylation
procedure: 2 eq AgOTf, 1 eq p-NO2PhSCl, 3Å MS, 0.9 eq
acceptor: i) 27, ii)-iv) 11
Deprotection of the levulinic ester 42 was accomplished under the same conditions
as before with hydrazine to give acceptor 43 in 98% yield.
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Scheme 2.26: Synthesis of acceptor 43 via deprotection of the levulinic ester
42 with hydrazine.
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2.2.4 Synthesis of Arabinose and Glucuronic Acid Donors
After having established a reliable way to synthesize various xylan backbones,
the respective arabinose and glucuronic acid donors needed to be synthesized.
For arabinose the N -phenyl trifluoroacetimidate 46 has been chosen because
of previous experience with this strategy in this department.207 The donor
is synthesized in three steps from L-arabinose according to a procedure by
Callam et al.208 At first, the methyl glycoside 44 is formed followed by complete
benzoylation in one step. Hydrolysis leads to the hemiacetal 45, which can then
be converted to the acetimidate 46. Compound 46 was stored in the freezer.
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Scheme 2.27: Synthesis of arabinose N -phenyl trifluoroacetimidate 46.
The glucuronic acid ester donors can be synthesized from commercially available
glucose pentaacetate according to known procedures.209,210 The peracetylated
glucose is first transformed into the thioethyl glucoside after which the acetyl
groups are removed under Zemplen conditions. The primary alcohol can be
selectively tritylated to give compound 48 in 54% yield over three steps. The
free hydroxyl groups were then benzylated and the trityl group removed to yield
the primary alcohol 50.
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Scheme 2.28: Synthesis of glucuronic acid ester precursor 50.
The first attempt to isolate the carboxylic acid 52 failed due to formation of the
oxidation product 51 which was isolated in 25% yield as it was the most polar
compound on TLC (Scheme 2.31).
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CH2Cl2/H2O
50 51
Scheme 2.29: A longer reaction time leads to oxidation of sulfur.
Reducing the reaction time to 45 minutes allowed for isolation of carboxylic acid
52 in high yield, indicating that the alcohol is more reactive towards oxidation
than the thioglycoside.
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Scheme 2.30: Synthesis of glucuronic acid 52.
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Subsequent methylation of the acid has been accomplished using trimethylsilyl-
diazomethane in 88% yield. Contrary to its non-silylated cousin diazomethane,
this reagent is less toxic, labile and explosive. Additionally, it has been found
to give better yields in some cases.211 The great advantage of this reaction is
that the only major side product is nitrogen gas and TMSOMe, leaving a clean
product behind.
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Scheme 2.31: Synthesis of glucuronic acid ester 53.
In order to introduce a methyl group at the 4-position (see p. 8), acetal 54
was prepared in three steps from peracetylated glucose in 51% yield over three
steps. The remaining two hydroxyl groups are benzylated and the acetal cleaved
afterwards. The primary alcohol group in diol 56 can be tritylated as before,
giving compound 57 with its free hydroxyl group at the 4-position.
The free hydroxyl group can now be methylated using sodium hydride and
methyl iodide. The trityl group is then removed again and the primary alcohol
oxidized with TEMPO/BAIB.212 The acid 59 is methylated with trimethylsilyl-
diazomethane, giving the donor 60 in quantitative yield.
60 Results
AcO O OAcAcO
OAc
O O SEtHO
OH
1. BF3•Et2O, EtSH
2. NaOMe/MeOH
3. PhCH(OMe)2
    CSA
OPh
O O SEtBnO
OBn
OPh
51%
75%
BnBr, NaH,
DMF
HO O SEtBnO
OBn
HO O SEtBnO
OBn
MeO O SEtBnO
OBn
OAc
pTSA,
MeOH/CH2Cl2
92%
TrtCl, Py
89%
1. NaH, MeI
2. pTSA, MeOH
HO
TrtO HO
68%
MeO O SEtBnO
OBn
HO
OTEMPO,
BAIB
CH2Cl2/H2O
73%
MeO O SEtBnO
OBn
MeO
O
TMSCHN2
quant.
47 54
555657
58 59 60
Scheme 2.32: Synthesis of glucuronic acid ester 60.
Coupling with Xylan acceptors
The attachment of arabinose to the xylan backbone has been accomplished using
the arabinose donor 46. Keeping the reaction temperature at -40°C, the reaction
with xylan 38 goes to completion within less than 30 minutes when TMSOTf
was used as the promoter. The heptasaccharide 61 was isolated with a yield of
46%, averaging about 77% for each of the three glycosylations.
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Scheme 2.33: Coupling between triol 38 and acetimidate 46 leads to formation
of heptasaccharide 61.
The anomeric thiophenyl group was removed via hydrolysis with NBS in a mixture
of acetone and water, giving heptasaccharide 62 in 76% yield (Scheme 2.34).
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Scheme 2.34: Removal of the thiophenyl group on the anomeric position with
NBS.
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The last step constists of removing the remaining benzoyl groups. This has been
done with sodium methoxide in methanol. Full consumption of UV active material
was achieved after 48 hours according to TLC. HRMS acquisition confirmed
that the target molecule 63 has been obtained. Unfortunately, purification via
reverse phase chromatography has been problematic and the compound has not
yet been fully purified. NMR analysis showed no unusual signals, such as from
an elimination reaction. It is possible that the quenching of the reaction mixture
led to some decomposition of the target molecule. Further work on this problem
is being continued by a colleague.
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Scheme 2.35: Removal of remaining benzoyl groups gives target molecule 63
Synthesis of the glucuronoxylan was planned to be executed according to a
procedure described by Oscarson and Svahnberg.191 In that procedure the
coupling to a xylose disaccharide was accomplished using DMTST in diethyl
ether with complete α-selectivity. Applying the same conditions, 1.5 equivalents
of donor 60 and four equivalents of freshly prepared DMTST were mixed with
acceptor 43 at 0°C. Because of the lower solubility of the acceptor, the reaction
had to be conducted in a mixture of diethyl ether and dichloromethane. Contrary
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to Oscarson’s 30 minutes, the reaction never went to completion. While some
product formation could be observed, it was the donor that was fully consumed
instead of the acceptor. Addition of more donor and DMTST did not solve
that problem and even after 20 hours there was acceptor left next to several
side products. Isolation of the product was attempted, but failed because of
inseparable impurities. Instead of DMTST, NIS was used in the hope that the
reactivity would be in favour of a coupling between acceptor and donor. However,
the donor decomposed again, only this time faster than before within one hour
at -10°C (Scheme 2.36).
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Scheme 2.36: Coupling between donor 60 and acceptor 43 was performed
under different reaction conditions. Using DMTST and
NIS/TESOTf lead to many side products and decomposition of
the donor. Although some product is formed, it’s inseparable
from the other side products.
To increase the reactivity of the donor, another strategy was pursued in which
the donor was reacted with bromine to give the glycosyl bromide 65. After
generating the bromide, the mixture was simply quenched and washed and the
solvent removed. The crude product was then dissolved in dry dichloromethane
together with the acceptor 43. The mixture was cooled down to -30°C and silver
triflate was added. This time the reaction gave a clean formation of the product.
Both anomers were obtained as an inseparable mixture in a ratio of 1:1. In order
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to shift the ratio towards the α-anomer, silver perchlorate was used instead of
silver triflate and 10% ether was added as solvent (Any more ether leads to
precipitation of the acceptor.). This resulted in isolation of both anomers in a
ratio of 7:3 and a yield of 64%. Also, 15% of the acceptor was recovered, giving
an adjusted yield of 75%.
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Scheme 2.37: Thioglycoside 60 was brominated and then coupled with AgClO4
to give a mixture of anomers (7 α: 3 β) in 75% yield brsm.
Since the anomeric mixture is inseparable, the hexasaccharide 64 was debenzoylat-
ed so that the two anomers might be separated via reverse-phase chromatography.
2.3 Conclusion 65
OO
BzO
O
O
O
OBz
BzO
BzO O
O
OBz
BzO O
OBz
OBzO O OBn
OBz
BzO
OMe
O
OBn
OBn
MeO
O
OO
HO
O
O
O
OH
HO
HO O
O
OH
HO O
OH
OHO O OBn
OH
HO
OMe
O
OBn
OBn
MeO
O
NaOMe,
MeOH/CH2Cl2
64
66
Scheme 2.38: Hexasaccharide 64 was deprotected with sodium methoxide to
give polyol 66. Purification of this compound has so far been
unsuccessful.
A first attempt to separate the mixture by HPLC did not succeed and gave
only an impure mixture of compounds. Additionally there have been technical
problems with the ELS detector. The presence of the compound could be verified
via HRMS. Further work on this problem is being continued by a colleague.
2.3 Conclusion
It has been shown that the step-wise glycosylation method based on preactivation
is a viable path towards arabinoxylans as well as glucuronoxylans. The building
blocks are easily accessible and the method allows for a rapid assembly of at
least pentaxylans. While investigating the synthetic strategy to build the xylan
backbone the following key results have been obtained:
• A better understanding has been gained on how the reaction temperature
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influences the competition between aglycon transfer and glycosylation.
• A new way to purify the promoter by sublimation has been found.
• A new protocol has been established that allows the synthesis of oligoxylans
with up to at least five units in consistently high yields.
Furthermore it has been shown that the chosen protecting group strategy allows
for an easy deprotection of the xylan backbone. It also gives one both options on
where to install the branching sugars. It has been shown that either the O-2 or O-
3 position are easily accessible and conceivably both positions could be accessed
at the same time. Attaching arabinose or glucuronic acid donors to the backbone
has been accomplished via the acetimidate method and the Koenigs-Knorr
coupling, respectively. While the arabinoxylan has been completely deprotected,
there remains the challenge of purifying the reaction mixture. In the same
way, the purification of the single α-anomer of the glucuronoxylan needs to be
optimized.
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2.4 Future Work
This project is being continued by two coworkers in our group. As of now, the
strategy has been extended towards utilizing xylose building blocks containing
two Lev-groups on the O-2 as well as O-3 position. The following oligosaccharides
have so far been synthesized (yields refering to last synthetic step):213
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The work is being continued towards the synthesis of a series of new arabinoxy-
lans with different substitution patterns. Furthermore, the purification of the
(partially) deprotected oligosaccharides is currently being investigated.
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Chapter 3
Experimental Data
3.1 General
All material, reagents and solvents were purchased from Alfa Aesar, Carbosynth,
Sigma-Aldrich or TCI chemicals and used without further purification unless
specified otherwise. All solvents were HPLC-grade. The dry solvents were
obtained from an Innovative Technology PS-MD-7 Pure-solv solvent purification
system. Reactions requiring anhydrous conditions were carried out in flame-dried
glassware under inert atmosphere, either using argon or nitrogen. Solvents were
removed under vacuum at 30°C. All reactions were monitored by thin-layer
chromatography (TLC), performed on Merck aluminum plates precoated with
0.25 mm silica gel 60 F254. Compounds were visualized under UV irradiation
and/or heating after applying a solution of Ce(SO4)2 (2.5 g) and (NH4)6Mo7O24
(6.25 g) in 10% aqueous H2SO4 (250 ml). Column chromatography was performed
using Geduran silica gel 60 with specified solvents given as volume ratio. 1D (1H
and 13C) and 2D (gCOSY, HSQC, HMBC) NMR spectra were recorded on a
Bruker Ascend 400 or a Varian Mercury 300 spectrometer. 2D NMR experiments
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were performed in order to elucidate the carbohydrate structures. Optical
rotations were measured with a Perkin-Elmer Model 241 Polarimeter with a path
length of 1 dm. High-resolution mass spectrometry (HRMS) data were recorded
on a Bruker SolariX XR 7T ESI/MALDI-FT-ICR MS, with external calibration
performed using NaTFA cluster ions. The elemental analyses were performed at
the Microanalytic Laboratory Kolbe in Mülheim an der Ruhr (Germany).
3.2 Experimental Procedures and Analytical
Data
General Procedure I - Tin-Mediated Glycosylation with Perbenzo-
ylated Glycosyl Bromide
A suspension of the unprotected acceptor 1 (0.5 mmol) and Bu2SnO (0.75 mmol)
in MeOH (3.0 ml) was refluxed until a clear solution was obtained (3 h). The
solvent was evaporated in vacuo followed by drying at high vacuum for 2 h to give
the stannylene derivative as a colorless foam. The bromide donor (0.9 mmol) and
4 Å MS (500 mg) were added to a solution of the stannylene derivative in CH2Cl2
(5 ml). The suspension was stirred at –30 °C for 30 min. AgOTf (0.9 mmol) was
then added, and the mixture was stirred in the dark while the temperature was
allowed to reach 10 °C. After 6 h the mixture was filtered, diluted with CH2Cl2,
washed once with 2 M aqueous HCl, once with saturated aqueous NaHCO3 and
once with water. The organic layer was dried (MgSO4), filtered and concentrated.
The crude product was purified by column chromatography (toluene/ acetone,
9:1).
General Procedure II - Glycosylation via Preactivation of Thiophenyl-
glycoside
To a two-necked 100 ml Schlenk flask are added 1 g powdered 3 Å molecular
sieves and a stirring bar. The necks are fitted with a stopper and a septum.
After flame drying the flask under vacuum and filling it with argon, a solution of
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0.361 mmol of donor in 3 ml dichloromethane and 2 equivalents of silver triflate
in 3 ml of toluene are added. The solution is left to stirr in the dark for 15
minutes and then cooled down to -60°C. One equivalent of p-nitrophenylsulfenyl
chloride in 1 ml of dichloromethane is added quickly and the solution is left to
stir for 5 minutes. Afterwards a solution of 0.9 equivalents of the acceptor are
added quickly and the temperature of the solution is kept between -45°C and
-55°C for 15 minutes after which it is left to warm up to -15°C. The mixture is
subsequently quenched with 3 equivalents of triethylamine, filtered through a
pad of Celite and purified via flash chromatography.
General Procedure III - Glycosylation with N -Phenyl
Trifluoroacetimidate donor
A mixture of the acceptor (0.08 mmol) and donor (1.1 equivalents per alcohol
group in acceptor) was co-evaporated with toluene and subjected to high vacuum
for 2h. The mixture was dissolved in 20 ml anhydrous CH2Cl2 and cooled to
-40°C. Trimethylsilyl trifluoromethanesulfonate (0.1 eq.) was added and the
reaction mixture was stirred at -40°C until TLC (toluene/EtOAc 20:1) showed
completion of the reaction (10-30 min). The reaction mixture was quenched
by addition of 0.7 eq. triethylamine, evaporated and purified by flash column
chromatography.
General Procedure IV - Deprotection of PMB-group
The PMB-ether (5.66 mmol) was dissolved in CH2Cl2/H2O (10:1, 30 ml), followed
by addition of DDQ (1.927 g, 8.49 mmol). The resulting mixture was stirred at
room temperature overnight. After the reaction was completed, it was diluted
with CH2Cl2, filtered through a pad of Celite, washed with a saturated aqueous
solution of NaHCO3 until the aqueous phase assumed a light yellow color, dried
over magnesium sulfate and purified by column chromatography.
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General Procedure V - Deprotection of Lev-group
The levulinic ester was dissolved in pyridine to provide a 1.4M solution. N+1
equivalents1 of 50% hydrazine hydrate in a 1M solution of pyridine/acetic acid
(2:1) are added to the solution. The reaction mixture is left to stir at room
temperature for 10 minutes, after which TLC indicated full consumption of the
starting material. Acetone (500 eq.) is added and the mixture is left to stir
for another 20 minutes. After addition of ethyl acetate, the solution is washed
with 10% HCl, saturated NaHCO3 and water. The organic phase is dried over
magnesium sulfate and the solvent removed in vacuo.
Purification of 4-nitrophenylsulfenyl chloride
A 100 ml Schlenk flask is filled with 2 g of 95% 4-nitrophenylsulfenyl chloride
(technical grade, melting point 43°C). The compound is sublimated at 35°C and
0.07 mbar. After three days 920 mg (46%) of the bright yellow product have
been obtained with a melting point of 47-51°C.
Synthesis of DMTST
DMTST was synthesized using methyl triflate and dimethyl disulfide according
to a literature procedure.214
HO O SPhHO
OH
(1) Phenyl 1-thio-β-D-xylopyranoside D-xylose
(50.0 g, 0.333 mol) was suspended in dichloromethane
(250 ml) together with Et3N (231 ml, 1.67 mol) and
DMAP (8.1 g, 0.067 mol), then acetic anhydride (126
ml, 1.33 mol) was added at 0°C. The reaction was stirred until TLC indicated full
conversion within 6 hours. The reaction mixture was washed with ice-water, 300
ml of 1 M HCl and brine (200 ml). The organic layers were dried over Na2SO4,
filtered and evaporated under reduced pressure. The crude, without further
purification, was dissolved in dichloromethane (300 ml). The stirred mixture
1N = number of Lev-groups in the molecule
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was cooled to 0 °C and thiophenol (41 ml, 0.400 mol) and BF3·OEt2 (122 ml,
0.999 mol) were added, under inert atmosphere. The solution was stirred at
room temperature until disappearance of the starting material on TLC, then
diluted with dichloromethane and washed successively with saturated sodium
hydrogen carbonate (2x250 ml) and water (2x150 ml), dried over Na2SO4,
filtrated and concentrated in vacuo. The residue was dissolved in methanol (200
ml) and a 0.1 M solution of sodium methoxide in methanol was added. After
15 min the mixture was neutralized with Amberlite IR-120(H+) resin, filtered,
and concentrated under reduced pressure. The crude was recrystallized in ethyl
acetate / heptane to yield 1 (29.5 g, 37%) as a white solid. 1H-NMR (400
MHz, MeOD) δ 7.57 – 7.48 (m, 2H, ArH), 7.37 – 7.23 (m, 3H, ArH), 4.57 (d,
J = 9.3 Hz, 1H, H-1), 3.95 (dd, J = 11.3, 5.2 Hz, 1H, H-5), 3.49 (ddd, J = 10.0,
8.8, 5.2 Hz, 1H, H-4), 3.36 (t, J = 8.6 Hz, 1H, H-3), 3.24 (dd, J = 11.3, 10.1 Hz,
1H, H-5), 3.22 (dd, J = 9.3, 8.5 Hz, 1H, H-2). 13C-NMR (101 MHz, MeOD) δ
133.5, 131.7, 128.5, 127.1, 88.7 (C-1), 77.8 (C-3), 72.3 (C-2), 69.5 (C-4), 69.0
(C-5). The data are in accordance with literature.215
BzO O
Br
BzO
OBz
(2) 2,3,4-Tri-O-benzoyl-α-D-xylopyranosyl
bromide The compound was prepared according to a
known procedure and the analytical data matched the
literature values.216,217 1H-NMR (300 MHz, CDCl3)
δ 8.04 – 7.91 (m, 5H), 7.59 – 7.30 (m, 10H), 6.82 (d,
J = 3.9 Hz, 1H, H-1), 6.24 (t, J = 9.8 Hz, 1H), 5.55 – 5.44 (m, 1H), 5.29 (dd,
J = 9.9, 4.0 Hz, 1H), 4.36 (dd, J = 11.3, 5.9 Hz, 1H), 4.14 (t, J = 11.1 Hz, 1H).
13C-NMR (75 MHz, CDCl3) δ 165.7, 165.6, 165.5, 133.9, 133.8, 133.5, 130.2,
130.0, 129.9, 129.1, 128.8, 128.7, 128.7, 128.5, 88.0, 71.6, 70.1, 69.0, 63.1.
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(3) Phenyl 2,3,4-tri-O-benzoyl-β-D-xylopyran-
osyl-(1→3)-[2,3,4-tri-O-benzoyl-β-D-xylopyra-
nosyl-(1→2)]-1-thio-β-D-xylopyranoside This
compound was synthesized according to General
Procedure I. 1H-NMR (300 MHz, CDCl3) δ 8.03 –
7.94 (m, 12H), 7.58 – 7.44 (m, 7H), 7.43 – 7.31 (m,
13H), 7.15 – 7.06 (m, 2H), 6.96 (m, 1H), 5.87 (t, J = 8.4 Hz, 1H, C-3), 5.80 (t,
J = 7.6 Hz, 1H, B-3), 5.50 – 5.33 (m, 4H, B-2, B-4, C-2, C-4), 5.20 (d, J =
5.5 Hz, 1H, B-1), 4.90 (d, J = 6.4 Hz, 1H, C-1), 4.83 (d, J = 4.5 Hz, 1H, A-1),
4.58 – 4.51(m, 2H, C-5a, B-5a), 4.28 (dd, J = 12.5, 2.6 Hz, 1H, A-5a), 4.06 (t,
J = 5.2 Hz, 1H, A-3), 3.96 – 3.94 (m, 1H, A-4), 3.79 – 3.60 (m, 4H, C-5b, B-5b,
A-2), 3.41 (dd, J = 12.3, 5.3 Hz, 1H, A-5b). 13C-NMR (75 MHz, CDCl3) δ
165.7, 165.7, 165.7, 165.6, 165.6, 165.4, 133.6, 133.5, 133.4, 133.3, 130.7, 130.1,
130.0, 130.0, 129.9, 129.6, 129.3, 129.3, 129.3, 129.2, 129.0, 128.8, 128.6, 128.6,
128.5, 128.4, 127.0, 99.9 (C-1), 99.2 (B-1), 88.1 (A-1), 76.1 (A-3), 73.9 (A-4),
71.3 (C-4), 71.1 (C-3), 70.8 (B-3), 70.8 (C-2), 70.7 (A-2), 69.5 (B-4), 69.3 (B-2),
62.6 (B-5), 61.9 (C-5), 61.1 (A-5).
O
BzO
BzO
BzO
O
OAc
O
AcO SPhA
B
(4) Phenyl 2,3,4-tri-O-benzoyl-β-D-xy-
lopyranosyl-(1→3)-2,4-di-O-acetyl-1-
thio-β-D-xylopyranoside This compound
was prepared according to General Procedure
I, using acetonitrile as solvent during the glycosylation. To allow for full
characeterization, the remaining hydroxyl groups were acetylated by mixing the
compound with acetyl chloride in pyridine over 24 hours. 1H-NMR (400 MHz,
CDCl3) δ 8.08 – 8.01 (m, 2H), 8.00 – 7.96 (m, 4H), 7.59 – 7.49 (m, 3H), 7.44 –
7.34 (m, 4H), 7.36 – 7.27 (m, 2H), 7.25 – 7.20 (m, 5H), 5.72 (t, J = 6.1 Hz, 1H,
B-3), 5.37 (dd, J = 6.1, 4.4 Hz, 1H, B-2), 5.28 (td, J = 5.5, 3.8 Hz, 1H, B-4),
5.13 (d, J = 4.3 Hz, 1H, B-1), 5.04 – 4.98 (m, 2H, A-1, A-2), 4.96 (td, J = 5.9,
3.9 Hz, 1H, A-4a), 4.48 (dd, J = 12.5, 3.7 Hz, 1H, B-5a), 4.40 (dd, J = 12.4, 3.7
Hz, 1H, A-5a), 4.07 (t, J = 5.7 Hz, 1H, A-3), 3.80 (dd, J = 12.4, 5.4 Hz, 1H,
B-5b), 3.52 (dd, J = 12.4, 5.8 Hz, 1H, A-5b), 2.11 (s, 3H, Ac), 2.06 (s, 3H, Ac).
13C-NMR (101 MHz, CDCl3) δ 170.0 (Ac), 169.6 (Ac), 165.7 (Bz), 165.3 (Bz),
165.2 (Bz), 134.5, 133.6, 133.4, 131.3, 130.1, 130.1, 130.0, 129.5, 129.4, 129.2,
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128.9, 128.6, 128.5, 127.5, 99.3 (B-1), 86.1 (A-1), 74.8 (A-3), 70.3 (A-2), 69.6
(B-2), 69.4 (B-3), 69.1 (A-4), 68.7 (B-4), 62.6 (A-5), 60.9 (B-5), 21.2 (Ac), 21.1
(Ac).
O
BzO
BzO
BzO O
OAc
AcO
O SPhAB
(5) Phenyl 2,3,4-tri-O-benzoyl-β-D-xy-
lopyranosyl-(1→4)-2,3-di-O-acetyl-1-
thio-β-D-xylopyranoside This compound
was prepared according to General Procedure
I, using acetonitrile as solvent during the glycosylation. To allow for full
characeterization, the remaining hydroxyl groups were acetylated by mixing the
compound with acetyl chloride in pyridine over 24 hours. 1H-NMR (300 MHz,
CDCl3) δ 8.03 – 7.99 (m, 2H), 7.97 – 7.93 (m, 4H), 7.59 – 7.49 (m, 3H), 7.48 –
7.32 (m, 7H), 7.33 – 7.27 (m, 3H), 7.17 (m, 1H), 5.72 (t, J = 6.9 Hz, 1H, B-3),
5.29 – 5.17 (m, 3H, A-3, B-2, B-4), 4.92 – 4.85 (m, 2H, A-2, B-1,), 4.68 (d, J =
9.2 Hz, 1H, A-1), 4.40 (dd, J = 12.2, 4.0 Hz, 1H, B-5a), 4.09 (dd, J = 11.8, 5.1
Hz, 1H, A-5a), 3.89 (td, J = 9.4, 5.2 Hz, 1H, A-4), 3.70 (dd, J = 12.2, 6.5 Hz,
1H, B-5b), 3.32 (dd, J = 11.7, 9.8 Hz, 1H, B-5a), 2.08 (s, 2H, Ac), 2.06 (s, 3H,
Ac). 13C-NMR (75 MHz, CDCl3) δ 170.1 (Ac), 169.7 (Ac), 165.7 (Bz), 165.4
(Bz), 165.1 (Bz), 133.6, 132.9, 130.0, 130.0, 129.9, 129.1, 128.6, 128.4, 125.4, 99.8
(B-1), 86.5 (A-1), 75.3 (A-4), 73.7 (A-3), 70.4 (A-2, B-2), 69.9 (B-3), 68.9 (B-4),
66.7 (A-5), 61.3 (B-5), 21.04 (Ac), 20.96 (Ac).
O
O
BzO
BzO
O
Ph SPh
(6) 3,4-Di-O-benzoyl-1,2-O-(phenylthiobenz-
ylidene)-α-D-xylopyranose 1H-NMR (300 MHz,
CDCl3) δ 8.05 – 7.97 (m, 5H), 7.91 – 7.88 (m, 2H),
7.59 – 7.49 (m, 4H), 7.41 – 7.29 (m, 9H), 5.69 (t, J =
5.4 Hz, 1H, H-3), 5.42 – 5.37 (m, 2H, H-1, H-2), 5.19
– 5.15 (m, 1H, H-4), 4.41 (dd, J = 12.6, 3.2 Hz, 1H, H-5a), 3.81 (dd, J = 12.6,
4.7 Hz, 1H, H-5b). 13C-NMR (75 MHz, CDCl3) δ 165.7, 165.4, 133.7, 133.6,
130.2, 130.1, 130.1, 129.3, 129.0, 128.7, 110.0 (PhC(O)2SPh), 94.9 (C-1), 69.2
(C-3), 68.6 (C-2), 68.2 (C-4), 54.7 (C-5).
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(8) 3,4-di-O-benzoyl-α-D-xylopyranose-1,2-di-
yl(1-O-phenylthio-β-D-xylopyranoside)-4-yl
orthobenzoate 1H-NMR (300 MHz, CDCl3) δ 7.98
(d, J = 7.2 Hz, 2H), 7.80 (d, J = 7.3 Hz, 2H), 7.66
– 7.61 (m, 2H), 7.54 – 7.45 (m, 2H), 7.41 – 7.36 (m,
4H), 7.35 – 7.24 (m, 3H), 7.21 – 7.17 (m, 3H), 7.11 – 7.06 (m, 2H), 5.92 (d, J =
4.7 Hz, 1H, B-1), 5.62 (t, J = 2.7 Hz, 1H, B-3), 5.21 – 5.15(m, 1H, B-4), 4.66
– 4.63 (m, 1H, B-2), 4.39 (d, J = 9.2 Hz, 1H, A-1), 4.04 (dd, J = 12.2, 6.5
Hz, 1H B-5a), 3.87 (dd, J = 11.5, 4.5 Hz, 1H, A-5a), 3.56 – 3.44 (m, 3H, A-3,
A-4, B-5b), 3.24 (td, J = 9.1, 2.6 Hz, 1H, A-2), 3.13 (dd, J = 11.5, 9.5 Hz, 1H,
A-5b), 3.03 (d, J = 1.7 Hz, 1H, OH), 2.79 (d, J = 2.6 Hz, 1H, OH). 13C-NMR
(75 MHz, CDCl3) δ 165.4 (Bz), 164.9 (Bz), 135.5, 133.9, 133.5, 132.6, 132.3,
130.1, 130.0, 129.9, 129.1, 128.9, 128.7, 128.5, 128.3, 128.2, 126.3, 125.4, 121.6
(PhC(O)3), 97.3 (B-1), 88.8 (A-1), 76.0 (A-4), 73.7 (B-2), 72.3 (A-2), 71.9 (A-3),
68.9 (B-3), 67.9 (A-5), 67.8 (B-4), 59.9 (B-5).
BzO O SPhBzO
OBz
(9) Phenyl 2,3,4-tri-O-benzoyl-1-thio-β-D-xy-
lopyranoside The triol 1 (5.12 g, 21.13 mmol) was
dissolved in pyridine (45 ml) and BzCl (7.4 ml, 63.40
mmol). The reaction mixture was stirred at room
temperature for 1 h and the excess of BzCl was quenched by adding 10 ml of
methanol and the mixture was stirred for additional 10 minutes. The disappear-
ance of a white precipitate was observed. The reaction mixture was diluted with
dichloromethane and washed with 1 M HCl (2x100 ml) and water (2x100 ml).
The organic phase was dried over Na2SO4, filtered and the solvent evaporated
in vacuo. The residue was purified by column chromatography to afford 9 (5.1 g,
84%).218 Rf = 0.28 (3 ethyl acetate / 7 heptane) 1H-NMR (400 MHz, CDCl3)
δ 8.06 - 8.03 (m, 2H), 8.01 - 7.98 (m, 4H), 7.56 - 7.51 (m, 5H), 7.42 - 7.32 (m,
9H), 5.79 - 5.76 (m, 1H), 5.48 - 5.45 (m, 1H), 5.32 - 5.27 (m, 2H), 4.71 (dd,
J = 12.3, 4.0 Hz, 1H), 3.83 (dd, J = 12.3, 6.5 Hz, 1H). 13C-NMR (101 MHz,
CDCl3) δ 165.6, 165.3, 165.3, 133.6, 133.5, 133.5, 133.2, 132.8, 130.2, 130.1,
130.1, 129.3, 129.2, 129.0, 128.6, 128.6, 128.5, 128.3, 86.5, 70.6, 70.1, 68.8, 63.7.
Elemental Analysis: calc. C: 69.30 H: 4.73 S: 5.78; found: C: 69.26 H: 4.70 S:
5.66
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(10) Phenyl 4-O-p-methoxybenzyl-1-thio-β-D-
xylopyranoside Phenyl thioxyloside 1 (29.5 g, 0.122
mol) was solubilized in DMF (200 ml) with CSA (2.83
g, 0.012 mol) and 2-methoxypropene (37.3 ml, 0.366 mol). The reaction was
stirred at 60 °C for 1 hour then cooled to room temperature and quenched
with Et3N (30 ml). The solvent was evaporated and the residue purified by
column chromatography (heptane/ethyl acetate/CH2Cl2 4:1:1). 24.1 g (70%)
of the phenyl 2,3-O-isopropylidene 1-thio-β-D-xylopyranoside was isolated as a
colorless oil.200 1H-NMR (400 MHz, CDCl3) δ 7.56 – 7.48 (m, 2H, ArH), 7.36
– 7.27 (m, 3H, ArH), 4.51 (d, J = 9.4 Hz, 1H, H-1), 4.11 (dd, J = 11.2, 5.2 Hz,
1H, H-5), 3.71 (ddd, J = 10.3, 8.8, 5.2 Hz, 1H, H-4), 3.55 (t, J = 8.7 Hz, 1H,
H-3), 3.34 (dd, J = 9.4, 8.6 Hz, 1H, H-2), 3.32 (dd, J = 11.2, 10.3 Hz, 1H, H-5),
2.17 (s, 6H, 2xCH3). 13C-NMR (101 MHz, CDCl3) δ 133.0, 132.0, 129.0, 128.3,
111.5, 85.6 (C-1), 83.0i (C-3), 75.3 (C-2), 70.0 (C-4), 69.1 (C-5), 26.8 (CH3),
26.7 (CH3). The data are in accordance with the literature.219
A solution of the previously isolated compound (17.5 g, 62 mmol), PMBCl (10.9
ml, 80.6 mmol) and NaH (60% oil dispersion, 3.0 g, 74.4 mmol) in DMF (120
ml) was stirred for 16 h at room temperature, then quenched with 10% HCl
solution (28 ml). The reaction mixture was diluted with dichloromethane (100
ml) and washed with NaHCO3 (300 ml) and successively brine (200 ml). The
organic layers were collected and dried over Na2SO4, filtered and concentrated
in vacuo. The crude compound was dissolved in CH2Cl2/CH3OH (1:1, 200
ml) and stirred with CSA (14.4 g, 62 mmol) at room temperature overnight.
When complete conversion was observed, the reaction was quenched by Et3N
and concentrated. Silica gel purification (6 heptane : 4 ethyl acetate, Rf 0.17)
afforded 10 (20.5 g, 91%). [α]20D = −59 (c 1.0, CHCl3), 1H-NMR (400 MHz,
CDCl3) δ 7.59 – 7.46 (m, 2H, ArH), 7.35 – 7.21 (m, 5H, ArH), 6.93 – 6.83
(m, 2H, ArH), 4.61 (d,J = 11.2 Hz, 1H, OCH2Ph), 4.57 (d, J = 11.2 Hz, 1H,
OCH2Ph), 4.55 (d, J = 8.9 Hz, 1H, H-1), 4.06 (dd, J = 11.5, 4.8 Hz, 1H, H-5),
3.80 (s, 3H, OCH3), 3.66 (t, J = 8.6 Hz, 1H, H-3), 3.46 (ddd, J = 9.6, 8.6, 4.8
Hz, 1H, H-4), 3.40 (t, J = 8.6 Hz, 1H, H-2), 3.27 (dd, J = 11.5, 9.7 Hz, 1H,
H-5). 13C-NMR (101 MHz, CDCl3) δ 159.7, 132.8, 132.2, 130.0, 129.7, 129.2,
128.3, 127.6, 114.1, 88.8 (C-1), 76.6 (C-4), 76.5 (C-3), 72.8 (OCH2Ph), 72.1
(C-2), 67.1 (C-5), 55.4 (OCH3). HRMS (MALDI) m/z calcd for C19H22O5S
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(M+Na+) 385.1080, found 385.1090.
O
OBz
BzO
HO SPh
(11) Phenyl 2,3-di-O-benzoyl-1-thio-β-D-xylo-
pyranoside The diol 10 (0.680 g, 1.88 mmol) was
dissolved in pyridine (5 ml) and BzCl (0.436 ml, 3.75
mmol) was added. The reaction mixture was stirred
at 22 °C for 2 h, then it was diluted with dichloromethane and washed with 1 M
HCl (2x20 ml) and water (2x20 ml). The organic phase was dried over Na2SO4,
filtered and the solvent removed under vacuum. The residue was purified by
column chromatography to afford the dibenzoylated product which is used in
the next step. (0.877 g, 82%). [α]20D = + 55.0 (c 1.0, CHCl3).
1H-NMR (400
MHz, CDCl3) δ 7.99 – 7.95 (m, 4H), 7.56 – 7.51 (m, 2H), 7.50 – 7.46 (m, 2H),
7.42 –7.34 (m, 4H), 7.31 – 7.27 (m, 3H), 7.15 – 7.12 (m, 2H), 6.74 – 6.71 (m,
2H), 5.60 (t, J = 8.0 Hz, 1H, H-3), 5.34 (t, J = 8.0 Hz, 1H, H-2), 5.04 (d, J =
8.1 Hz, 1H, H-1), 4.55 (d, J = 11.8 Hz, 1H, OCH2Ph), 4.52 (d, J = 11.8 Hz,
1H, OCH2Ph), 4.28 (dd, J = 11.9, 4.6 Hz, 1H, H-5), 3.79 – 3.74 (m, 1H, H-4),
3.75 (s, 3H, OCH3), 3.57 (dd, J = 11.9, 8.5 Hz, 1H, H-5). 13C-NMR (101 MHz,
CDCl3) δ 165.7 (Bz), 165.4 (Bz), 159.5, 133.4, 133.2, 132.5, 130.1, 130.0, 129.7,
129.7, 129.5, 129.4, 129.1, 128.5, 128.5, 128.1, 113.9, 86.9 (C-1), 73.9 (C-3), 73.6
(C-4), 72.5 (OCH2Ph), 70.6 (C-2), 66.4 (H-5), 55.3 (OCH3). HRMS (MALDI)
m/z calcd for C33H30O7S (M+Na+) 593.1604, found 593.1617.
The compound 20 obtained in the previous step was converted to the acceptor
11 according to General Procedure IV and was obtained as a white solid in 87%
yield after column chromatography (heptane/ethyl acetate 7:3, Rf 0.18). [α]20D
= + 63.7 (c 1.0, CHCl3). 1H-NMR (400 MHz, CDCl3) δ 8.07 – 7.97 (m, 4H,
ArH), 7.58 – 7.47 (m, 4H, ArH), 7.45 – 7.38 (m, 4H, ArH), 7.34 – 7.29 (m, 3H,
ArH), 5.43 (t, J = 7.4 Hz, 1H, H-2), 5.33 (t, J = 7.4 Hz, 1H, H-3), 5.09 (d, J =
7.3 Hz, 1H, H-1), 4.45 (dd, J = 12.0, 4.4 Hz, 1H, H-5), 4.00 (td, J = 7.6, 4.4 Hz,
1H, H- 4), 3.61 (dd, J = 12.0, 7.6 Hz, 1H, H-5). 13C-NMR (101 MHz, CDCl3)
δ 167.1 (Bz), 165.2 (Bz), 133.8, 133.6, 133.0, 132.8, 130.2, 130.0, 129.3, 129.2,
128.9, 128.7, 128.6, 128.3, 86.8 (C-1), 76.0 (C-3), 70.2 (C-2), 68.4 (C-4), 67.6
(C-5). Elemental Analysis: calc. C: 66.65 H: 4.92 S: 7.12; found: C: 66.64 H:
4.89 S: 6.99
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(12) Phenylsulfenyl chloride Into a three-neck, round-
bottom flask (1 L), fitted with an argon inlet, a pressure-
equalizing dropping funnel (500 ml), and a magnetic stir bar,
was charged with thiophenol (84 ml), dry triethylamine (1
ml), and dry pentane (400 ml) under a blanket of argon. The remaining neck
of the flask was stoppered and the argon was allowed to sweep gently through
the flask and out of the pressure-equalizing dropping funnel. The flask and its
contents were cooled to 0° C. with an ice bath and stirring was begun. The
dropping funnel was charged with sulfuryl chloride (76 ml). The sulfuryl chloride
was added dropwise over a 1-hr period to the chilled thiophenol solution with
stirring. During this addition, a thick layer of white solid formed. It gradually
dissolved as it was broken apart. After the addition was complete, the ice
bath was removed and the mixture was allowed to stir for 1 h longer while
slowly warming to room temperature. During the course of the addition and
subsequent stirring, the clear, pale-yellow solution became dark orange-red. The
dropping funnel was replaced with an outlet adapter connected to a vacuum
pump and the argon inlet was exchanged for a ground glass stopper. The
pentane and excess sulfuryl chloride were removed under reduced pressure at
room temperature. After this, the outlet adapter was replaced by a short-path
distillation apparatus adapted for use under reduced pressure. The oily red
residue was distilled to give phenylsulfenyl chloride as a blood-red liquid (26 g,
87%), by 41-42° C. (1.5 mm). This compound was stored under argon until
used.201 1H-NMR (400 MHz, CDCl3) δ 7.70 – 7.65 (m, 2H), 7.46 – 7.39 (m,
3H). 13C-NMR (101 MHz, CDCl3) δ 135.7, 131.9, 130.2, 129.5.
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(13) Phenyl 2,3,4-tri-O-benzoyl-β-D-xylo-
pyranosyl-(1→4)-2,3-O-benzoyl-1-thio-β-D-
xylopyranoside This compound was obtained
according to General Procedure II in a yield of 79%
after purification by column chromatography (Rf = 0.18 (3 ethyl acetate / 7
heptane)) [α]20D = −22 (c 1.0, CHCl3), 1H-NMR (400 MHz, CDCl3) δ 8.02 –
7.91 (m, 11H), 7.56 – 7.50 (m, 5H), 7.45 – 7.38 (m, 9H), 7.36 – 7.33 (m, 3H),
7.28 – 7.27 (m, 2H), 5.67 (t, J = 7.9 Hz, 1H, A-3), 5.63 (t, J = 6.6 Hz, 1H, B-3),
5.34 (t, J = 8.0 Hz, 1H, A-2), 5.24 (dd, J = 6.5, 5.0 Hz, 1H, B-2), 5.06 – 5.01
(m, 1H, B-4), 5.02 (d, J = 8.1 Hz, 1H, A-1), 4.95 (d, J = 4.8 Hz, 1H, B-1), 4.27
(dd, J = 12.2, 4.7 Hz, 1H, A-5a), 4.09 (td, J = 8.3, 4.9 Hz, 1H, A-4), 4.03 (dd,
J = 12.4, 3.9 Hz, 1H, B-5a), 3.55 (dd, J = 12.1, 8.6 Hz, 1H, A-5b), 3.43 (dd,
J = 12.4, 6.3 Hz, 1H, B-5b). 13C-NMR (101 MHz, CDCl3) δ 165.6 (Bz), 165.5
(Bz), 165.4 (Bz), 165.4 (Bz), 165.2 (Bz), 133.6, 133.43, 132.68, 130.08, 130.06,
130.01, 129.94, 129.90, 129.55, 129.42, 129.32, 129.13, 128.58, 128.54, 128.20,
99.8 (CH, B-1), 86.8 (CH, A-1), 75.2 (CH, A-4), 73.1 (CH, A-3), 70.6 (CH,
A-2), 70.2 (CH, B-2), 69.7 (CH, B-3), 68.6 (CH, B-4), 65.6 (CH2, A-5), 60.9
(CH2, B-5). HRMS (MALDI) m/z calcd for C51H42O13S (M+Na+) 917.2238,
found 917.2258.
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(14) Phenyl 2,3,4-tri-O-benzo-
yl-β-D-xylopyranosyl-(1→4)-2,3-
O-benzoyl-β-D-xylopyranosyl-
(1→4)-2,3-O-benzoyl-β-1-thio-β-
D-xylopyranoside This compound has been obtained in 69% yield applying
General Procedure II in a one-pot fashion. 1H-NMR (400 MHz, CDCl3) δ 8.00
– 7.90 (m, 15H), 7.58 – 7.46 (m, 7H), 7.43 – 7.27 (m, 18H), 5.64 – 5.58 (m, 2H,
2xCH, A-3, C-3), 5.54 (t, J = 8.1 Hz, 1H, CH, B-3), 5.36 – 5.26 (m, 1H, CH,
A-2), 5.23 – 5.13 (m, 2H, 2xCH, B-2, C-2), 5.03 (m, 1H, CH, C-4), 4.98 (d, J =
8.1 Hz, 1H, CH, A-1), 4.75 (d, J = 6.5 Hz, 1H, CH, B-1), 4.73 (d, J = 5.0 Hz,
1H, CH, C-1), 4.15 (dd, J = 12.0, 4.7 Hz, 1H, CH2, A-5a), 4.05 – 3.95 (m, 2H,
CH, A-4, CH2, C-5a ), 3.84 (td, J = 8.2, 4.9 Hz, 1H, CH, B-4), 3.57 (dd, J =
12.3, 4.7 Hz, 1H, B-5a), 3.48 (dd, J = 12.0, 8.7 Hz, 1H, A-5b), 3.37 (dd, J =
12.3, 6.3 Hz, 1H, C-5b), 3.17 (dd, J = 12.2, 8.6 Hz, 1H, B-5b). 13C-NMR (101
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MHz, CDCl3) δ 165.5 (Bz), 165.5 (Bz), 165.4 (Bz), 165.3 (Bz), 165.3 (Bz), 165.2
(Bz), 165.0 (Bz), 133.5, 133.5, 133.4, 133.3, 133.2, 132.8, 132.6, 130.1, 130.0,
130.0, 129.9, 129.9, 129.8, 129.6, 129.5, 129.5, 129.3, 129.2, 129.1, 129.0, 128.6,
128.5, 128.5, 128.5, 128.4, 128.1, 101.1 (CH, B-1), 99.5 (CH, C-1), 86.7 (CH,
A-1), 75.8 (CH, A-4), 74.9 (CH, B-4), 73.1 (CH, A-3), 72.1 (CH, B-3), 71.5 (CH,
B-2), 70.4 (CH, A-2), 70.1 (CH, A-2), 69.7 (CH, B-3), 68.6 (CH, C-4), 65.8
(CH2, A-5), 62.2 (CH2, B-5), 60.9 (CH2, C-5). HRMS (MALDI) m/z calcd
for C70H58O19S (M+Na+) 1257.3185, found 1257.3192
O
OTMS
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(15) Phenyl 2,3,4-tri-O-trimethylsilyl-1-thio-β-
D-xylopyranoside To a mixture of the triol 1 (1
g, 4.13 mmol) and triethylamine (3.65 ml, 26.0
mmol) in anhydrous CH2Cl2 (10.5 ml) was added
chlorotrimethylsilane (2.20 ml, 17.33 mmol) at 0°C under argon atmosphere.
The reaction was gradually warmed up to room temperature and kept stirring
over night. TLC showed full consumption of starting material. The solvent was
evaporated under reduced pressure, the residue was diluted with hexane (50 ml),
and the resulting mixture was filtered through Celite. The filtrate was concen-
trated in vacuo, and the residue was purified by flash column chromatography
(5% ethylacetate in pentane) to provide 15 (1.77 g, 3.86 mmol, 93% yield) as a
colorless oil.220 1H-NMR (300 MHz, CDCl3) δ 7.49 – 7.45 (m, 2H), 7.32 – 7.28
(m, 2H), 7.27 – 7.22 (m, 1H), 4.66 (d, J = 8.0 Hz, 1H, H-1), 3.99 (dd, J = 11.4,
4.8 Hz, 1H, H-5a), 3.63 – 3.55 (m, 1H, H-4), 3.53 – 3.40 (m, 2H, H-2, H-3), 3.20
(dd, J = 11.4, 9.2 Hz, 1H, H-5b), 0.25 – 0.24 (m, 9H, 3xCH3), 0.19 – 0.17 (m,
9H, 3xCH3), 0.16 – 0.14 (m, 9H, 3xCH3).
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O
OH
BnO
HO SPh
(16) Phenyl 3-O-benzyl-1-thio-β-D-xylopyrano-
side This compound was prepared according to a literature
procedure, but was only isolated in trace amounts.147 1H-
NMR (400 MHz, CDCl3) δ 7.53 – 7.51 (m, 2H), 7.38 –
7.28 (m, 8H), 4.69 (d, J = 11.8 Hz, 1H), 4.64 (d, J = 11.8 Hz, 1H), 4.56 (d, J =
9.0 Hz, 1H), 4.10 (dd, J = 11.5, 4.8 Hz, 1H), 3.69 (td, J = 8.4, 2.5 Hz, 1H), 3.49
(ddd, J = 9.6, 8.5, 4.8 Hz, 1H), 3.43 – 3.38 (m, 1H), 3.30 (dd, J = 11.5, 9.7 Hz,
1H), 2.70 (d, J = 3.0 Hz, 1H), 2.68 (d, J = 2.5 Hz, 1H). 13C-NMR (101 MHz,
CDCl3) δ 138.0, 132.9, 132.1, 129.2, 128.8, 128.3, 128.3, 128.0, 88.9, 76.9, 76.6,
73.2, 72.1, 67.1.
O
OBz
HO
PMBO SPh
(18) Phenyl 2-O-benzoyl-4-O-p-methoxybenz-
yl-1-thio-β-D-xylopyranoside An aqueous 1M
solution of sodium hydroxide (7.00 ml) was added
with vigorous stirring at -5°C to a solution of diol 67
(1g, 2.76 mmol), tetrabutylammonium hydrogen sulfate (0.187 g, 0.552 mmol)
and benzoyl chloride (0.43 ml, 3.72 mmol) in CH2Cl2 (50.0 ml). The mixture
was stirred for 30 min. (TLC indicated traces of disubstituted product and
traces of starting material). The organic layer was separated, washed with
water, dried and concentrated. Column chromatography (1.5 ethyl acetate / 8.5
hexane) afforded the benzyl ester 18 (877 mg, 1.88 mmol, 68%). Rf = 0.23 (3
ethyl acetate / 7 heptane) [α] = −12.0 (c 1.0, CHCl3), 1H-NMR (400 MHz,
CDCl3) δ 8.11 – 8.09 (m, 2H), 7.62 – 7.59 (m, 1H), 7.49 – 7.49(m, 4H), 7.30 –
7.28 (m, 5H), 6.90 – 6.88 (m, 2H), 5.09 – 5.05 (m, 1H), 4.80 (d, J = 9.6 Hz, 1H),
4.66 (d, J = 11.5 Hz, 1H), 4.61 (d, J = 11.5 Hz, 1H), 4.12 (dd, J = 11.5, 5.0
Hz, 1H), 3.89 – 3.85 (m, 1H), 3.82 (s, 3H), 3.60 (ddd, J = 9.8, 8.8, 5.1 Hz, 1H),
3.32 (dd, J = 11.4, 10.2 Hz, 1H). 13C-NMR (101 MHz, CDCl3) δ 166.1, 159.6,
133.5, 132.7, 130.1, 130.0, 129.8, 129.7, 129.1, 128.6, 128.1, 114.2, 114.2, 86.8,
77.1, 75.9, 73.1, 73.0, 67.6, 55.4. Elemental Analysis: calc. C: 66.94 H: 5.62
S: 6.87; found: C: 66.98 H: 5.59 S: 6.74
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O
OH
BzO
PMBO SPh
(19) Phenyl 3-O-benzoyl-4-O-p-methoxybenz-
yl-1-thio-β-D-xylopyranoside The compound is
prepared according to the same procedure as com-
pound 18 and obtained in 13% yield. Rf = 0.16 (3
ethyl acetate / 7 heptane) 1H-NMR (400 MHz, CDCl3) δ 8.14 – 8.07 (m, 2H,
ArH), 7.60 – 7.52 (m, 1H, ArH), 7.52 – 7.40 (m, 4H, ArH), 7.31 – 7.13 (m, 5H,
ArH), 6.81 – 6.74 (m, 2H, ArH), 5.31 (t, J = 5.6 Hz, 1H, H-3), 5.08 (d, J =
4.9 Hz, 1H, H-1), 4.58 (d, J = 11.7 Hz, 1H, OCH2Ph), 4.55 (d, J = 11.7 Hz,
1H, OCH2Ph), 4.37 (dd, J = 11.5, 2.2 Hz, 1H, H-5), 3.80 (t, J = 5.2 Hz, 1H,
H-2), 3.74 (s, 3H, OCH3), 3.67 – 3.56 (m, 2H, H- 4, H-5). 13C-NMR (101 MHz,
CDCl3) δ 165.9 (Bz), 159.7, 134.2, 133.6, 132.2, 130.2, 129.7, 129.5, 129.3, 129.2,
128.6, 127.9, 127.6, 114.1, 89.2 (C-1), 73.1 (C- 4), 72.0 (OCH2Ph), 71.6 (C-3),
70.4 (C-2), 62.7 (C-5), 55.4 (OCH3).
O
OBz
BzO
PMBO SPh
(20) Phenyl 2,3-di-O-benzoyl-4-O-p-methoxy-
benzyl-1-thio-β-D-xylopyranoside
The diol 10 (0.680 g, 1.88 mmol) was dissolved in
pyridine (5 ml) and BzCl (0.436 ml, 3.75 mmol) was
added. The reaction mixture was stirred at 22 °C for 2 h, then it was diluted
with dichloromethane and washed with 1 M HCl (2x20 ml) and water (2x20
ml). The organic phase was dried over Na2SO4, filtered and the solvent removed
under vacuum. The residue was purified by column chromatography to afford
the diester 20 (0.990, 84%). [α]20D = + 55.0 (c 1.00, CHCl3).
1H-NMR (400
MHz, CDCl3) δ 7.99 – 7.95 (m, 4H), 7.56 – 7.51 (m, 2H), 7.50 – 7.46 (m, 2H),
7.42 –7.34 (m, 4H), 7.31 – 7.27 (m, 3H), 7.15 – 7.12 (m, 2H), 6.74 – 6.71 (m,
2H), 5.60 (t, J = 8.0 Hz, 1H, H-3), 5.34 (t, J = 8.0 Hz, 1H, H-2), 5.04 (d, J =
8.1 Hz, 1H, H-1), 4.55 (d, J = 11.8 Hz, 1H, OCH2Ph), 4.52 (d, J = 11.8 Hz,
1H, OCH2Ph), 4.28 (dd, J = 11.9, 4.6 Hz, 1H, H-5), 3.79 – 3.74 (m, 1H, H-4),
3.75 (s, 3H, OCH3), 3.57 (dd, J = 11.9, 8.5 Hz, 1H, H-5). 13C-NMR (101
MHz, CDCl3) δ 165.7 (Bz), 165.4 (Bz), 159.5, 133.4, 133.2, 132.5, 130.1, 130.0,
129.7, 129.7, 129.5, 129.4, 129.1, 128.5, 128.5, 128.1, 113.9, 86.9 (C-1), 73.9
(C-3), 73.6 (C-4), 72.5 (OCH2Ph), 70.6 (C-2), 66.4 (H-5), 55.3 (OCH3). HRMS
(MALDI) m/z calcd for C33H30O7S (M+Na+) 593.1604, found 593.1617.
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O
OBz
ClAcO
PMBO SPh
(21) Phenyl 2-O-benzoyl-3-O-chloroacetyl-
4-O-p-methoxybenzyl-1-thio-β-D-xylopyrano-
side Compound 18 (500 mg, 1.07 mmol) was dissolved
in CH2Cl2 (10.70 ml) and pyridine (0.58 ml, 7.18 mmol), and thereafter,
chloroacetyl chloride (0.17 ml, 2.14 mmol) was added to the solution while
cooling on ice. The obtained mixture was stirred at room temperature for 4
hours. After completion of the reaction, the reaction solution was extracted
with CH2Cl2, washed with HCl, and then dehydrated with MgSO4, followed
by vacuum concentration. The resultant was purified by silica gel column
chromatography (toluene : ethyl acetate = 15 : 1), so as to obtain compound 21
(440 mg, 0.810 mmol, 76% yield). 1H-NMR (400 MHz, CDCl3) δ 8.02 – 7.99
(m, 2H), 7.61 – 7.56 (m, 1H), 7.46 – 7.40 (m, 4H), 7.30 – 7.26 (m, 3H), 7.22 –
7.18 (m, 2H), 6.90 – 6.85 (m, 2H), 5.35 (t, J = 8.8 Hz, 1H), 5.14 (t, J = 9.1 Hz,
1H), 4.84 (d, J = 9.3 Hz, 1H), 4.55 (d, J = 11.8 Hz, 1H), 4.50 (d, J = 11.8 Hz,
1H), 4.15 (dd, J = 6.8, 5.0 Hz, 1H), 3.87 (d, J = 14.7 Hz, 1H), 3.84 (d, J =
14.7 Hz, 1H), 3.81 (s, 3H), 3.69 (td, J = 9.6, 5.1 Hz, 1H), 3.41 (dd, J = 11.7,
9.8 Hz, 1H). 13C-NMR (101 MHz, CDCl3) δ 166.7, 165.4, 159.7, 133.6, 132.8,
132.4, 130.1, 129.7, 129.7, 129.2, 129.1, 128.7, 128.3, 114.1, 87.0, 76.4, 74.3,
72.9, 70.6, 67.5, 55.4, 40.6. HRMS (MALDI) m/z calcd for C28H27ClO7S
(M+Na+) 566.1136, found 566.1145.
OHO
ClAcO OBz
SPh
(22) Phenyl 2-Obenzoyl-3-O-chloroacetyl-1-
thio-β-D-xylopyranose This compound was pre-
pared according to General Procedure IV in 89% yield.
1H-NMR (400 MHz, CDCl3) δ 8.06 – 7.98 (m, 3H),
7.62 – 7.57 (m, 1H), 7.49 – 7.43 (m, 6H), 7.33 – 7.26 (m, 3H), 5.25 – 5.18 (m,
2H), 4.96 – 4.93 (m, 1H), 4.30 (dd, J = 11.8, 4.9 Hz, 1H), 4.05 (d, J = 14.9 Hz,
1H), 3.99 (d, J = 14.9 Hz, 1H), 3.93 (td, J = 8.6, 5.0 Hz, 2H), 3.49 (dd, J =
11.8, 8.9 Hz, 1H). 13C-NMR (101 MHz, CDCl3) δ 167.5, 165.3, 133.8, 132.9,
132.5, 130.0, 129.2, 128.7, 128.6, 128.4, 126.4, 86.9, 77.4, 70.2, 68.3, 68.1, 40.7.
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OO
ClAcO
OBz
O
OBz
BzO
BzO
SPh
(23) Phenyl 2,3,4-tri-O-benzoyl-β-D-xylo-
pyranosyl-(1→4)-2-O-benzoyl-3-O-chloro-
acetyl-1-thio-β-D-xylopyranoside This com-
pound was prepared according to General Procedure
II in 42% yield. 1H-NMR (400 MHz, CDCl3) δ 8.08 – 7.98 (m, 4H), 7.98 –
7.94 (m, 4H), 7.64 – 7.46 (m, 7H), 7.44 – 7.36 (m, 9H), 7.33 – 7.26 (m, 1H), 5.75
(t, J = 7.3 Hz, 1H, H-3’), 5.45 (t, J = 8.8 Hz, 1H, H-3), 5.30 (dd, J = 7.3, 5.4
Hz, 1H, H-2’), 5.27 (dd, J = 7.1, 4.4 Hz, 1H, H-4’), 5.20 (t, J = 9.1 Hz, 1H,
H-2), 4.91 (d, J = 5.4 Hz, 1H, H-1’), 4.83 (d, J = 9.3 Hz, 1H, H-1), 4.40 (dd,
J = 12.2, 4.3 Hz, 1H, H-5a’), 4.18 – 4.09 (m, 1H, H-5a), 4.06 – 3.96 (m, 3H,
CH2Cl, H-4), 3.71 (dd, J = 12.2, 7.0 Hz, 1H, H-5b’), 3.40 (dd, J = 11.8, 9.8
Hz, 1H, H-5b). 13C-NMR (101 MHz, CDCl3) δ= 166.7 (ClAc), 165.6 (Bz),
165.5 (Bz), 165.4 (Bz), 165.1 (Bz), 133.7, 133.6, 133.6, 133.3, 133.2, 131.9, 130.1,
130.0, 130.0, 129.9, 129.8, 129.2, 129.2, 129.1, 129.1, 129.0, 128.7, 128.6, 128.6,
128.5, 100.5 (H-1’), 86.7 (H-1), 75.7 (C-4), 75.6 (C-3), 70.6 (C-2’), 70.4 (C-2),
70.2 (C-3’), 69.0 (H-4’), 66.9 (C-5), 61.8 (C-5’), 40.8 (CH2Cl).
O
OBz
LevO
PMBO SPh
(24) Phenyl 2-O-benzoyl-3-O-levulinoyl-4-O-
p-methoxybenzyl-1-thio-β-D-xylopyranoside
A solution of DCC (4.56 g, 22.08 mmol) and DMAP
(0.135 g, 1.104 mmol) in CH2Cl2 (5.51 ml) was added
to a solution of 18 (5.15 g, 11.04 mmol) and 4-oxopentanoic acid (1.92 g, 16.56
mmol) in CH2Cl2 (55.10 ml) at 0°C. After stirring for 40 min at ambient
temperature, the mixture was filtered and the filtrate was concentrated in vacuo.
Purification by column chromatography (3 ethyl acetate / 7 heptane) afforded
6.18 g of product (10.94 mmol, 99 %). Rf = 0.21 (3 ethyl acetate / 7 heptane)
[α] = +15 (c 1.0, CHCl3), 1H-NMR (400 MHz, CDCl3) δ 8.02 – 7.99 (m, 2H),
7.59 – 7.55 (m, 1H), 7.44 – 7.40 (m, 4H), 7.29 – 7.27 (m, 2H), 7.25 – 7.22 (m,
2H), 6.88 – 6.85 (m, 2H), 5.34 – 5.30 (m, 1H), 5.17 – 5.12 (m, 1H), 4.90 (d, J =
8.5 Hz, 1H), 4.58 (d, J = 11.7 Hz, 1H), 4.53 (d, J = 11.7 Hz, 1H), 4.14 (dd,
J = 11.8, 4.8 Hz, 1H), 3.80 (s, 3H), 3.68 – 3.62 (m, 1H), 3.44 (dd, J = 11.8,
9.0 Hz, 1H), 2.66 – 2.50 (m, 3H), 2.46 – 2.39 (m, 1H), 2.06 (s, 3H). 13C-NMR
(101 MHz, CDCl3) δ 206.1, 171.9, 165.4, 159.6, 133.5, 133.0, 132.5, 130.1, 129.9,
129.7, 129.5, 129.1, 128.6, 128.1, 114.0, 86.9, 74.0, 72.8, 70.7, 66.9, 55.4, 38.0,
29.8, 28.2. HRMS (MALDI) m/z calcd for C31H32O8S (M+Na+) 587.1710,
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found 587.1722.
O
OBz
LevO
HO SPh
(25) Phenyl 2-O-benzoyl-3-O-levulinoyl-1-
thio-β-D-xylopyranoside This compound has been
prepared, starting from compound 24 according to
General Procedure IV in 83% yield. [α] = 0 (c 1.0,
CHCl3), Rf = 0.13 (4.5 ethyl acetate/5.5 heptane) 1H-NMR (400 MHz,
CDCl3) δ 8.04 – 8.01 (m, 2H), 7.61 – 7.57 (m. 1H), 7.47 – 7.44 (m, 4H), 7.29 –
7.28 (m, 3H), 5.23 – 5.16 (m, 2H), 4.94 – 4.91 (m, 1H), 4.29 (dd, J = 11.8, 4.9
Hz, 1H), 3.94 – 3.89 (m, 1H), 3.49 (dd, J = 11.8, 9.1 Hz, 1H), 2.80 – 2.63 (m,
2H), 2.54 (ddd, J = 13.4, 8.3, 5.1 Hz, 1H), 2.40 (ddd, J = 16.7, 6.4, 5.5 Hz, 1H)
, 2.10 (s, 3H). 13C-NMR (101 MHz, CDCl3) δ 207.7, 172.8, 165.3, 133.6, 132.9,
132.7, 130.1, 129.4, 129.1, 128.7, 128.2, 87.1, 76.8, 76.4, 70.3, 68.5, 68.3, 38.5,
29.8, 28.4. HRMS (MALDI) m/z calcd for C23H24O7S (M+Na+) 467.1135,
found 467.1145.
O
OLev
BzO
PMBO SPh
(26) Phenyl 3-O-benzoyl-2-O-levulinyl-
4-O-p-methoxybenzyl-1-thio-β-D-xylo-
pyranoside Compound 19 (1.0 g, 2.14 mmol)
was dissolved in dichloromethane (30 ml) followed
by addition of DCC (0.53 g, 2.57 mmol), DMAP (0.261 g, 2.14 mmol) and
LevOH (0.33 ml, 3.22 mmol). A white precipitate formed and complete
conversion was observed after 40 minutes at 22°C. The reaction mixture was
filtered through a Celite pad and the filtrate was concentrated to dryness. The
residue was purified by column chromatography (heptane/ethyl acetate, 7:3)
to give 26 as a colorless amorphous solid (1.21 g, 98%). [α]20D = −13.3 (c 0.27,
CHCl3). 1H-NMR (400 MHz, CDCl3) δ 8.03 - 7.98 (m, 2H, ArH), 7.62 - 7.56
(m, 1H, ArH), 7.52 - 7.42 (m, 4H, ArH), 7.35 - 7.28 (m, 3H, ArH), 7.13 - 7.07
(m, 2H, ArH), 6.74 - 6.68 (m, 2H, ArH), 5.42 (t, J = 8.4 Hz, 1H, H-3), 5.04
(t, J = 8.6 Hz, 1H, H-2), 4.82 (d, J = 8.7 Hz, 1H, H-1), 4.51 (d, J = 11.9 Hz,
1H, OCH2Ph), 4.47 (d, J = 11.9 Hz, 1H, OCH2Ph), 4.17 (dd, J = 11.8, 4.9 Hz,
1H, H-5), 3.74 (s, 3H, OCH3), 3.69 (td, J = 9.2, 4.9 Hz, 1H, H-4), 3.44 (dd,
J = 11.8, 9.2 Hz, 1H, H-5), 2.63 - 2.43 (m, 4H, 2x CH2), 2.04 (s, 3H, CH3).
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13C-NMR (101 MHz, CDCl3) δ 205.8 (Lev), 171.4 (Lev), 165.6 (Bz), 159.4,
133.3, 132.7, 132.5, 130.0, 129.6, 129.5, 129.0, 128.4, 128.1, 113.8, 86.6 (C-1),
74.2 (C-3), 73.9 (C-4), 72.4 (OCH2Ph), 70.3 (C-2), 66.9 (C-5), 55.2 (OCH3), 37.8
(CH2), 29.6 (CH2), 28.0 (CH3). HRMS (MALDI) m/z calcd for C31H32O8S
(M+Na+) 587.1710, found 587.2781.
O
OLev
BzO
HO SPh
(27) Phenyl 3-O-benzoyl-2-O-levulinoyl-1-
thio-β-D-xylopyranoside This compound was
prepared according to General Procedure IV
in 90% yield. [α]20D = + 25.6 (c 0.70, CHCl3).
1H-NMR (400 MHz, CDCl3) δ 8.23 – 7.89 (m, 2H, ArH), 7.70 – 7.28 (m, 8H,
ArH), 5.20 – 5.13 (m, 2H, H-2, H-3), 4.96 – 4.90 (m, 1H, H-1), 4.38 (dd, J =
11.9, 4.4 Hz, 1H, H-5), 3.95 – 3.87 (m, 1H, H-4), 3.54 (dd, J = 11.9, 7.9 Hz, 1H,
H-5), 2.72 – 2.65 (m, 2H, CH2), 2.65 – 2.50 (m, 2H, CH2), 2.09 (s, 3H, CH3).
13C-NMR (101 MHz, CDCl3) δ 205.9 (Lev), 171.2 (Lev), 166.9 (Bz), 133.7,
132.9, 132.5, 130.2, 129.1, 128.9, 128.6, 128.1, 86.4 (C-1), 75.7 (C-3), 69.7 (C-2),
68.2 (C-4), 67.3 (C-5), 37.9 (CH2), 29.6 (CH2), 28.0 (CH3). HRMS (MALDI)
m/z calcd for C23H24O7S (M+Na+) 467.1134, found 467.1146.
O
OBz
BzO
BzO O
OBz
LevO
O
SPh
(28) Phenyl 2,3,4-tri-O-benzoyl-β-D-xylo-
pyranosyl-(1→4)-2-O-benzoyl-3-O-levulinoyl-
1-thio-β-D-xylopyranoside This compound was
prepared according to General Procedure II in 86%
yield. Purification was accomplished by flash chromatography (Rf = 0.20 (4
ethyl acetate / 6 heptane)). [α]20D = - 41.4 (c 1.0 , CHCl3),
1H-NMR (400 MHz,
CDCl3) δ 8.05 – 8.00 (m, 4H), 7.98 – 7.92 (m, 4H), 7.63 – 7.45 (m, 6H), 7.42 –
7.32 (m, 9H), 7.28 – 7.27 (m, 2H), 5.70 (t, J = 6.5 Hz, 1H), 5.40 (t, J = 8.3 Hz,
1H), 5.31 – 5.21 (m, 2H), 5.16 (t, J = 8.4 Hz, 1H), 4.94 (d, J = 4.7 Hz, 1H,
H-1’), 4.89 (d, J = 8.6 Hz, 1H, H-1), 4.48 (dd, J = 12.4, 3.8 Hz, 1H), 4.19 (dd,
J = 12.0, 4.9 Hz, 1H), 3.99 (td, J = 8.7, 5.0 Hz, 1H), 3.75 (dd, J = 12.4, 6.1 Hz,
1H), 3.44 (dd, J = 12.0, 9.1 Hz, 1H), 2.67 – 2.50 (m, 3H), 2.51 – 2.41 (m, 1H),
1.97 (s, 3H). 13C-NMR (101 MHz, CDCl3) δ 205.9, 171.5, 165.7, 165.5, 165.4,
165.2, 133.6, 133.5, 132.9, 132.7, 132.5, 130.3, 130.1, 130.0, 129.9, 129.6, 129.3,
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129.2, 129.2, 129.1, 129.1, 128.7, 128.6, 128.6, 128.6, 128.3, 99.4, 86.7, 74.6, 73.2,
70.7, 70.2, 69.6, 68.7, 66.1, 61.1, 37.9, 29.6, 28.1. Elemental Analysis: calc.
C: 66.21 H: 4.99 S: 3.61; found: C: 66.01 H: 5.00 S: 3.59
O
OBz
BzO
BzO O
OBz
HO
O
SPh
(29) Phenyl 2,3,4-tri-O-benzoyl-β-D-xylo-
pyranosyl-(1→4)-2-O-benzoyl-1-thio-β-D-
xylopyranoside This compound was prepared
according to General Procedure V in 90% yield.
[α]20D = -24 (c 1.0, CHCl3),
1H-NMR (400 MHz, CDCl3) δ 8.12 – 8.10 (m, 2H),
7.97 – 7.92 (m, 6H), 7.62 – 7.52 (m, 3H), 7.50 – 7.46 (m, 3H), 7.41 – 7.32 (m,
8H), 7.27 – 7.26 (m, 3H), 5.86 – 5.81 (m, 1H), 5.43 (dd, J = 8.7, 7.1 Hz, 1H),
5.40 – 5.34 (m, 1H), 5.15 – 5.10 (m, 1H), 4.86 (d, J = 6.9 Hz, 1H), 4.74 (d,
J = 9.9 Hz, 1H), 4.46 (dd, J = 11.8, 5.0 Hz, 1H), 3.95 – 3.86 (m, 2H), 3.82 –
3.76 (m, 1H), 3.74 (bs, 1H), 3.68 (dd, J = 11.7, 9.2 Hz, 1H), 3.32 – 3.27 (m,
1H). 13-C NMR (101 MHz, CDCl3) δ 165.7, 165.6, 165.6, 165.2, 133.7, 133.5,
133.4, 133.0, 132.3, 130.1, 130.0, 129.9, 129.8, 129.0, 129.0, 129.0, 128.7, 128.6,
128.5, 128.2, 101.7, 86.7, 80.4, 75.1, 72.2, 71.3, 71.1, 69.3, 67.1, 62.7. HRMS
(MALDI) m/z calcd for C44H38O12S (M+Na+) 813.1976, found 813.1992
O
OBz
BzO
HO OBn
(30) Benzyl 2,3-di-O-benzoyl-β-D-xylopyrano-
side Starting material 20 (200 mg, 0.350 mmol) and
the acceptor, benzyl alcohol (0.044 ml, 0.420 mmol),
were mixed in the reaction flask and dried overnight
on a vacuum line. The reactants were dissolved in dichloromethane (6 ml) and
cooled to -40 °C, NIS (94 mg, 0.420 mmol) and triflic acid (9 µl, 0.105 mmol)
were added to the stirring mixture. Full conversion of the starting material
was observed via TLC analysis after 3 hours and the reaction was neutralized
with Et3N (0.145 ml, 1.05 mmol). The resulting mixture was stirred with 6
ml of 1 M Na2S2O3 until the yellow color disappeared. The organic phase
was diluted with dichloromethane and washed with brine, dried over Na2SO4,
filtered, concentrated and purified with flash chromatography (6 heptane : 4
ethyl acetate) yielding 30 (0.155 g, 65%) as a white solid. The analytical data
are in accordance with the literature.221 1H-NMR (400 MHz, CDCl3) δ 7.99 –
7.94 (m, 4H, ArH), 7.59 – 7.19 (m, 11H, ArH), 5.43 (dd, J = 7.8, 6.0 Hz, 1H,
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H-2), 5.26 (t, J = 7.6 Hz, 1H, H-3), 4.89 (d, J = 12.2 Hz, 1H, OCH2Ph), 4.78
(d, J = 6.0 Hz, 1H, H-1), 4.65 (d, J = 12.2 Hz, 1H, OCH2Ph), 4.26 (dd, J =
12.0, 4.5 Hz, 1H, H-5), 4.01 (td, J = 7.6, 4.5 Hz, 1H, H-4), 3.54 (dd, J = 12.0,
7.8 Hz, 1H, H-5). 13C-NMR (101 MHz, CDCl3) δ 167.2 (Bz), 165.3 (Bz), 137.0,
133.7, 133.5, 130.1, 130.0, 129.4, 129.0, 128.6, 128.5, 128.5, 128.0, 99.1 (C-1),
75.4 (C-3), 70.5 (C-2), 70.4 (OCH2Ph), 68.7 (C-4), 64.6 (C-5).
O
OBz
BzO
BzO O
OBz
LevO
O O
OBz
BzO
O SPh
(31) Phenyl 2,3,4-tri-O-benzo-
yl-β-D-xylopyranosyl-(1→4)-2-O-
benzoyl-3-O-levulinoyl-β-D-xylo-
pyranosyl-(1→4)-2,3-di-O-benzo-
yl-β-1-thio-β-D-xylopyranoside This compound was prepared according to
general procedure I in 88% yield. Rf = 0.22 (4 acetone / 6 heptane) [α] = −24
(c 1.0, CHCl3), 1H-NMR (400 MHz, CDCl3) δ 7.93 – 7.83 (m, 13H), 7.53 –
7.21 (m, 22H), 5.58 (t,J = 6.6 Hz, 1H), 5.51 (t, J = 7.9 Hz, 1H), 5.23 – 5.18 (m,
2H), 5.17 – 5.13 (m, 1H), 5.09 (dd, J = 6.4, 4.9 Hz, 1H), 4.94 (dd, J = 8.2, 6.6
Hz, 1H), 4.89 (d, J = 8.1 Hz, 1H), 4.63 (d, J = 4.7 Hz, 1H), 4.58 (d, J = 6.4
Hz, 1H), 4.33 (dd, J = 12.4, 3.8 Hz, 1H), 4.06 (dd, J = 12.0, 4.7 Hz, 1H), 3.88
(td, J = 8.2, 4.9 Hz, 1H), 3.66-3.57 (m, 2H), 3.44 (dd, J = 12.2, 4.8 Hz, 1H),
3.38 (dd, J = 12.0, 8.6 Hz, 1H), 3.01 (dd, J = 12.2, 8.7 Hz, 1H), 2.57 – 2.31 (m,
4H), 1.89 (s, 3H). 13C-NMR (101 MHz, CDCl3) δ 205.9, 171.9, 165.6, 165.5,
165.4, 165.3, 165.2, 165.1, 133.6, 133.5, 133.5, 133.4, 133.3, 132.9, 132.6, 130.1,
130.1, 130.0, 129.9, 129.8, 129.6, 129.5, 129.4, 129.4, 129.2, 129.1, 129.1, 128.7,
128.6, 128.6, 128.5, 128.5, 128.2, 101.0, 99.2, 86.8, 75.6, 74.2, 73.1, 71.9, 71.6,
70.4, 70.2, 69.7, 68.8, 65.9, 62.2, 61.1, 37.8, 29.6, 28.0. HRMS (MALDI) m/z
calcd for C68H60O20S (M+Na+) 1251.3291, found 1251.3308.
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(34) Phenyl 2,3,4-tri-O-
benzoyl-β-D-xylopyran-
osyl-(1→4)-2-O-benzoyl-
3-O-levulinoyl-β-D-xylo-
pyranosyl-(1→4)-2,3-O-benzoyl-β-D-xylopyranosyl-(1→4)-2-O-ben-
zoyl-3-O-levulinoyl-β-1-thio-β-D-xylopyranoside This compound was
synthesized according to General Procedure II in 67% yield. Rf = 0.16 (4
acetone / 6 heptane) 1H-NMR (400 MHz, CDCl3) δ 8.02 – 7.87 (m, 15H), 7.61
– 7.46 (m, 6H), 7.47 – 7.41 (m, 5H), 7.40 – 7.34 (m, 10H), 7.35 – 7.26 (m, 2H),
7.25 – 7.23 (m, 2H), 5.65 (t, J = 6.5 Hz, 1H), 5.49 (t, J = 7.9 Hz, 1H), 5.31 –
5.26 (m, 2H), 5.24 – 5.20 (m, 1H), 5.17 – 5.13 (m, 1H), 5.11 – 5.07 (m, 2H), 5.02
(dd, J = 8.4, 6.6 Hz, 1H), 4.82 (d, J = 8.5 Hz, 1H), 4.72 (d, J = 4.6 Hz, 1H),
4.66 (d, J = 6.0 Hz, 1H), 4.66 (d, J = 6.6 Hz, 1H), 4.41 (dd, J = 12.4, 3.7 Hz,
1H), 4.05 (dd, J = 12.0, 4.8 Hz, 1H), 3.98 (dd, J = 12.2, 4.5 Hz, 1H), 3.95 –
3.86 (m, 1H), 3.82 (td, J = 8.6, 5.0 Hz, 1H), 3.74 (dt, J = 8.1, 4.1 Hz, 1H), 3.68
(dd, J = 12.5, 6.2 Hz, 1H), 3.55 (dd, J = 12.2, 4.7 Hz, 1H), 3.38 (dd, J = 12.0,
8.0 Hz, 1H), 3.32 (dd, J = 11.9, 9.1 Hz, 1H), 3.11 (dd, J = 12.2, 8.8 Hz, 1H),
2.64 – 2.30 (m, 8H), 1.97 (s, 3H), 1.95 (s, 3H). 13C-NMR (101 MHz, CDCl3) δ
206.0, 205.9, 171.9, 171.6, 165.6, 165.5, 165.4, 165.3, 165.2, 165.2, 165.1, 133.6,
133.5, 133.5, 133.4, 133.2, 132.8, 132.5, 130.1, 130.1, 130.1, 129.9, 129.8, 129.7,
129.5, 129.4, 129,4, 129.2, 129.1, 129.1, 128.6, 128.6, 128.4, 128.2, 100.8, 100.5,
99.1, 86.6, 77.4, 75.1, 74.9, 74.3, 73.0, 72.0, 71.9, 71.6, 71.1, 70.5, 70.1, 69.6, 68.7,
66.1, 62.5, 62.3, 61.0, 37.8, 37.8, 29.7, 29.7, 28.0, 28.0. HRMS (MALDI) m/z
calcd for C85H78O27S (M+Na+) 1585.4343, found 1585.4362.
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(35) Phenyl 2,3,4-tri-
O-benzoyl-β-D-xylo-
pyranosyl-(1→4)-2-O-
benzoyl-3-O-levulinoyl
-β-D-xylopyranosyl-(1→4)-2-O-benzoyl-β-D-xylopyranosyl-(1→4)-2-
O-benzoyl-β-1-thio-β-D-xylopyranoside This compound was prepared in
50% yield according to General Procedure II. Rf = 0.25 (4.5 acetone / 5.5
heptane) [α] = −20 (c 1.0, CHCl3), 1H-NMR (400 MHz, CDCl3) δ 7.94 – 7.78
(m, 17H), 7.57 – 7.37 (m, 7H), 7.36 – 7.25 (m, 11H), 7.26 – 7.19 (m, 2H), 7.18 –
7.15 (m, 2H), 5.57 (t, J = 6.6 Hz, 1H), 5.50 (t, J = 7.9 Hz, 1H), 5.36 (t, J =
8.2 Hz, 1H), 5.20 (t, J = 8.0 Hz, 1H), 5.18 – 5.00 (m, 4H), 4.88 (d, J = 8.1 Hz,
1H), 4.90 – 4.81 (m, 1H), 4.63 – 4.57 (m, 2H), 4.33 (d, J = 6.5 Hz, 1H), 4.36 –
4.27 (m, 1H), 4.03 (dd, J = 12.1, 4.8 Hz, 1H), 3.86 (td, J = 8.3, 5.0 Hz, 1H),
3.72 – 3.65 (m, 1H), 3.66 – 3.53 (m, 3H), 3.41 – 3.30 (m, 2H), 2.99 (dd, J =
12.1, 8.7 Hz, 1H), 2.92 (dd, J = 12.2, 8.6 Hz, 1H), 2.56 – 2.27 (m, 4H), 1.89 (s,
3H). 13C-NMR (101 MHz, CDCl3) δ 205.9, 171.8, 165.6, 165.4, 165.4, 165.3,
165.1, 165.1, 133.5, 133.5, 133.4, 133.2, 132.8, 132.6, 130.1, 130.0, 129.9, 129.9,
129.8, 129.8, 129.6, 129.5, 129.4, 129.2, 129.1, 129.1, 128.6, 128.6, 128.6, 128.5,
128.4, 128.2, 101.1, 100.6, 99.2, 86.7, 75.8, 75.2, 74.3, 73.1, 72.1, 71.9, 71.5, 71.4,
70.4, 70.2, 69.7, 68.8, 62.4, 62.2, 61.1, 53.9, 37.8, 29.4, 28.0. HRMS (MALDI)
m/z calcd for C87H76O26S (M+Na+) 1591.4238, found 1591.4253.
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(36) Phenyl 2,3,4-tri-O-benzoyl-β-
D-xylopyranosyl-(1→4)-2-O-ben-
zoyl-3-O-levulinoyl-β-D-xylopy-
ranosyl-(1→4)-2-O-benzoyl-3-O-
levulinoyl-1-thio-β-D-xylopyranoside This compound was synthesized
according to General Procedure II in 88% yield. (Rf = 0.35 (1 ethyl acetate : 1
heptane)). [α] = −36 (c 1.0, CHCl3), 1H-NMR (400 MHz, CDCl3) δ 8.02 –
7.92 (m, 11H), 7.61 – 7.51 (m, 5H), 7.49 – 7.43 (m, 4H), 7.40 – 7.32 (m, 8H),
7.25 – 7.24 (m, 2H), 5.70 (t, J = 6.6 Hz, 1H), 5.32 (t, J = 8.1 Hz, 1H), 5.27 –
5.23 (m, 3H), 5.10 (t, J = 8.3 Hz, 1H), 5.02 (dd, J = 8.3, 6.5 Hz, 1H), 4.93 (d,
J = 4.8 Hz, 1H), 4.83 (d, J = 8.5 Hz, 1H), 4.64 (d, J = 6.4 Hz, 1H), 4.45 (dd,
J = 12.4, 3.9 Hz, 1H), 4.08 – 4.05 (m, 1H), 4.04 – 4.01 (m, 1H), 3.92 (td, J =
8.1, 4.9 Hz, 1H), 3.82 (td, J = 8.6, 5.0 Hz, 1H), 3.73 (dd, J = 12.4, 6.2 Hz, 1H),
3.39 (dd, J = 12.1, 8.4 Hz, 1H), 3.33 (dd, J = 11.9, 9.0 Hz, 1H), 2.62 – 2.51
(m, 5H), 2.50 – 2.36 (m, 3H), 2.04 (s, 3H), 1.98 (s, 3H). 13C-NMR (101 MHz,
CDCl3) δ 206.1, 206.0, 172.0, 171.6, 165.6, 165.4, 165.3, 165.2, 133.5, 132.7,
132.6, 130.1, 130.1, 130.1, 130.0, 130.0, 129.5, 129.4, 129.3, 129.2, 129.1, 128.7,
128.6, 128.2, 100.6, 99.3, 86.6, 74.9, 74.3, 73.0, 71.9, 71.4, 70.5, 70.3, 69.7, 68.8,
66.1, 62.5, 61.2, 37.9, 37.9, 29.8, 29.7, 28.1. HRMS (MALDI) m/z calcd for
C66H62O21S (M+Na+) 1245.3397, found 1245.3412.
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(37) Phenyl 2,3,4-tri-O-
benzoyl-β-D-xylopyran-
osyl-(1→4)-2-O-benzoyl-
3-O-levulinoyl-β-D-xy-
lopyranosyl-(1→4)-2-O-benzoyl-3-O-levulinoyl-β-D-xylopyranosyl-
(1→4)-2-O-benzoyl-3-O-levulinoyl-β-1-thio-β-D-xylopyranoside This
compound was prepared according to general procedure II in 69% yield. Rf =
0.27 (1 acetone : 1 heptane), [α] = −54 (c 1.0, CHCl3), 1H-NMR (400 MHz,
CDCl3) δ 8.01 – 7.92 (m, 13H), 7.59 – 7.51 (m, 5H), 7.49 – 7.42 (m, 6H), 7.40 –
7.32 (m, 8H), 7.24 – 7.22 (m, 3H), 5.69 (t, J = 6.5 Hz, 1H), 5.32 (t, J = 8.2 Hz,
1H), 5.27 – 5.23 (m, 3H), 5.20 (t, J = 8.1 Hz, 1H), 5.08 (t, J = 8.4 Hz, 1H),
5.03 (dd, J = 8.2, 6.8 Hz, 1H), 4.96 (dd, J = 8.0, 6.6 Hz, 1H), 4.92 (d, J = 4.7
Hz, 1H), 4.81 (d, J = 8.4 Hz, 1H), 4.63 (d, J = 6.5 Hz, 1H), 4.56 (d, J = 6.3
Hz, 1H), 4.46 (dd, J = 12.4, 3.7 Hz, 1H), 4.04 – 4.02 (m, 1H), 4.01 – 3.99 (m,
1H), 3.95 – 3.89 (m, 2H), 3.80 – 3.71 (m, 3H), 3.38 (dd, J = 12.0, 8.5 Hz, 1H),
3.32-3.24 (m, 2H), 2.64 – 2.48 (m, 8H), 2.46 – 2.32 (m, 4H), 2.04 (s, 3H), 2.01 (s,
3H), 1.98 (s, 3H). 13C-NMR (101 MHz, CDCl3) δ 206.0, 205.9, 205.9, 171.8,
171.6, 171.5, 165.5, 165.3, 165.2, 165.1, 165.0, 133.4, 132.6, 132.4, 123.0, 129.9,
129.8, 129.4, 129.3, 129.1, 129.0, 128.9, 128.5, 128.4, 128.1, 100.3, 100.3, 99.1,
86.4, 74.7, 74.4, 74.2, 72.9, 71.9, 71.6, 71.3, 71.0, 70.3, 70.1, 69.5, 68.6, 65.9, 62.4,
61.0, 37.8, 37.7, 37.7, 29.7, 29.5, 27.9, 27.8. HRMS (MALDI) m/z calcd for
C83H80O28S (M+Na+) 1579.4449, found 1579.4480.
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(38) Phenyl 2,3,4-tri-O-
benzoyl-β-D-xylopyrano-
syl-(1→4)-2-O-benzoyl-β-
D-xylopyranosyl-(1→4)-2-
O-benzoyl-β-D-xylopyranosyl-(1→4)-2-O-benzoyl-β-1-thio-β-D-xylo-
pyranoside This compound was prepared according to General Procedure V in
97% yield. [α] = −38 (c 1.0, CHCl3), 1H-NMR (400 MHz, CHCl3) δ 8.06 –
7.99 (m, 5H), 7.96 – 7.90 (m, 6H), 7.63 – 7.51 (m, 5H), 7.49 – 7.42 (m, 6H),
7.43 – 7.31 (m, 8H), 7.25 – 7.21 (m, 2H), 7.21 – 7.13 (m, 3H), 5.82 (t, J = 8.9
Hz, 1H), 5.42 (dd, J = 9.0, 7.1 Hz, 1H), 5.42 – 5.31 (m, 1H), 5.12 – 4.99 (m,
3H), 4.82 (d, J = 7.0 Hz, 1H), 4.64 (d, J = 10.0 Hz, 1H), 4.50 (d, J = 7.9 Hz,
1H), 4.46 (d, J = 8.0 Hz, 1H), 4.46 – 4.42 (m, 1H), 3.87 – 3.54 (m, 13H), 3.34 –
3.23 (m, 1H), 3.26 – 3.12 (m, 2H). 13C-NMR (101 MHz, CDCl3) δ 165.7, 165.6,
165.6, 165.5, 165.2, 133.7, 133.5, 133.3, 132.9, 132.3, 130.1, 130.0, 129.9, 129.9,
129.8, 129.6, 129.4, 129.2, 129.0, 129.0, 128.9, 128.8, 128.6, 128.6, 128.5, 128.4,
128.2, 125.4, 102.3, 102.2, 102.0, 86.7, 80.7, 80.5, 80.3, 74.9, 73.3, 73.2, 73.0,
72.1, 71.3, 71.1, 69.4, 67.2, 63.6, 63.6, 62.9. HRMS (MALDI) m/z calcd for
C68H62O22S (M+Na+) 1285.3346, found 1285.3362.
OO
BzO
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SPh
O
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BzO
BzO
(39) Phenyl 2,3,4-tri-O-benzoyl-β-D-xylo-
pyranosyl-(1→4)-3-O-benzoyl-2-O-levu-
linoyl-1-thio-β-D-xylopyranoside This
compound was synthesized according to Gen-
eral Procedure II in 89% yield after purification via flash chromatography
(toluene/heptane/ethyl acetate 2:4:3). [α] = 43.6 (c 0.38, CHCl3). 1H-NMR
(400 MHz, CDCl3) δ 8.09 – 7.88 (m, 8H, ArH), 7.63 – 7.28 (m, 17H, ArH), 5.64
(t, J = 6.6 Hz, 1H, H-3’), 5.50 (t, J = 8.2 Hz, 1H, H-3), 5.22 (dd, J = 6.6, 4.9
Hz, 1H, H-2’), 5.09 (t, J = 8.5 Hz, 1H, H-2), 5.10 – 5.06 (m, 1H, H-4’), 4.91
(d, J = 4.8 Hz, 1H, H-1’), 4.83 (d, J = 8.6 Hz, 1H, H-1), 4.19 (dd, J = 12.0,
4.9 Hz, 1H, H-5), 4.09 – 3.95 (m, 2H, H-4, H-5’), 3.45 (dd, J = 12.0, 9.1 Hz,
1H, H-5), 3.43 (dd, J = 12.5, 6.1 Hz, 1H, H-5’), 2.72 – 2.41 (m, 4H, 2xCH2),
2.08 (s, 3H, CH3). 13C-NMR (101 MHz, CDCl3) δ 205.9 (Lev, C(O)), 171.3
(Lev, C(O)), 165.5 (Bz), 165.4 (Bz), 165.3 (Bz), 165.0 (Bz), 133.5, 133.5, 133.5,
132.8, 132.4, 130.0, 130.0, 129.9, 129.9, 129.5, 129.3, 129.1, 129.0, 128.6, 128.6,
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128.5, 128.5, 128.2, 99.7 (C-1’), 86.4 (C-1), 75.2 (C-4), 73.4 (C-3), 70.3 (C-2),
70.1 (C-2’), 69.5 (C-3’), 68.5 (C-4’), 66.0 (C-5), 60.8 (C-5’), 37.8 (CH2), 29.7
(CH2), 28.0 (CH2). HRMS (MALDI) m/z calcd for C49H44O14S (M+Na+)
911.2343, found 911.2362.
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(40) Phenyl 2,3,4-tri-O-benzoyl-β-
D-xylopyranosyl-(1→4)-3-O-benzoyl-
2-O-levulinoyl-β-D-xylopyranosyl-
(1→4)-2,3-di-O-benzoyl-1-thio-β-D-
xylopyranoside This compound was synthesized according to General
Procedure II in 66% yield after purification via flash chromatography
(toluene/heptane/ethyl acetate 2:1:1). [α] = 43.6 (c 0.38, CHCl3). 1H-NMR
(400 MHz, CDCl3) δ 8.09 – 7.88 (m, 8H, ArH), 7.63 – 7.28 (m, 17H, ArH), 5.64
(t, J = 6.6 Hz, 1H, H-3’), 5.50 (t, J = 8.2 Hz, 1H, H-3), 5.22 (dd, J = 6.6, 4.9
Hz, 1H, H-2’), 5.09 (t, J = 8.5 Hz, 1H, H-2), 5.10 – 5.06 (m, 1H, H-4’), 4.91
(d, J = 4.8 Hz, 1H, H-1’), 4.83 (d, J = 8.6 Hz, 1H, H-1), 4.19 (dd, J = 12.0,
4.9 Hz, 1H, H-5), 4.09 – 3.95 (m, 2H, H-4, H-5’), 3.45 (dd, J = 12.0, 9.1 Hz,
1H, H-5), 3.43 (dd, J = 12.5, 6.1 Hz, 1H, H-5’), 2.72 – 2.41 (m, 4H, 2xCH2),
2.08 (s, 3H, CH3). 13C-NMR (101 MHz, CDCl3) δ 205.9 (Lev, C(O)), 171.3
(Lev, C(O)), 165.5 (Bz), 165.4 (Bz), 165.3 (Bz), 165.0 (Bz), 133.5, 133.5, 133.5,
132.8, 132.4, 130.0, 130.0, 129.9, 129.9, 129.5, 129.3, 129.1, 129.0, 128.6, 128.6,
128.5, 128.5, 128.2, 99.7 (C-1’), 86.4 (C-1), 75.2 (C-4), 73.4 (C-3), 70.3 (C-2),
70.1 (C-2’), 69.5 (C-3’), 68.5 (C-4’), 66.0 (C-5), 60.8 (C-5’), 37.8 (CH2), 29.7
(CH2), 28.0 (CH3). HRMS (MALDI) m/z calcd for C49H44O14S (M+Na+)
911.2343, found 911.2362.
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(41) Phenyl 2,3,4-
tri-O-benzoyl-β-D-xy-
lopyranosyl-(1→4)-3-O-
benzoyl-2-O-levulinyl-
β-D-xylo-pyranosyl-(1→4)-2,3-di-O-benzoyl-β-D-xylopyranosyl-
(1→4)-2,3-di-O-benzoyl-1-thio-β-D-xylopyranoside This compound was
synthesized according to General Procedure II. (toluene/heptane/ethyl acetate
3:3:2). [α]20D = - 42.1 (c 0.38, CHCl3).
1H-NMR (400 MHz, CDCl3) δ 8.23 –
7.78 (m, 15H, ArH), 7.72 – 6.98 (m, 30H, ArH), 5.63 (t, J = 7.9 Hz, 1H, H-3),
5.57 (t, J = 6.7 Hz, 1H, H-3” ’), 5.46 (t, J = 7.7 Hz, 1H, H-3’), 5.35 – 5.25 (m,
2H, H-2, H-3”), 5.15 (dd, J = 7.9, 6.0 Hz, 1H, H-2’), 5.11 (dd, J = 9.1, 4.2 Hz,
1H, H-2” ’), 5.03 (td, J = 6.4, 4.1 Hz, 1H, H-4” ’), 4.99 (d, J = 8.0 Hz, 1H, H-1),
4.83 (dd, J = 8.7, 6.8 Hz, 1H, H-2”), 4.78 (d, J = 6.1 Hz, 1H, H-1’), 4.66 (d,
J = 4.9 Hz, 1H, H-1” ’), 4.35 (d, J = 6.8 Hz, 1H, H-1”), 4.18 (dd, J = 12.1, 4.7
Hz, 1H, H-5), 4.07 – 3.99 (m, 1H, H- 4), 3.97 (dd, J = 12.4, 3.9 Hz, 1H, H-5” ’),
3.79 – 3.63 (m, 3H, H-4”, H-4’, H-5’), 3.49 (dd, J = 8.5, 5.2 Hz, 1H, H-5), 3.46
(t, J = 6.1 Hz, 1H, H-5”), 3.33 (dd, J = 12.4, 6.3 Hz, 1H, H-5” ’), 3.28 (dd, J =
11.8, 8.0 Hz, 1H, H-5’), 3.02 (dd, J = 12.2, 9.1 Hz, 1H, H-5”), 2.63 – 2.45 (m,
2H, CH2), 2.44 – 2.28 (m, 2H, CH2), 2.06 (s, 3H, CH3). 13C-NMR (101 MHz,
CDCl3) δ 205.8 (Lev), 171.2 (Lev), 165.6 (Bz), 165.5 (Bz), 165.5 (Bz), 165.4
(Bz), 165.3 (Bz), 165.3 (Bz), 165.2 (Bz), 165.0 (Bz), 133.5, 133.5, 133.4, 133.4,
133.3, 133.2, 132.9, 132.6, 130.1, 130.0, 130.0, 129.9, 129.9, 129.8, 129.8, 129.7,
129.6, 129.5, 129.5, 129.4, 129.3, 129.2, 129.1, 129.0, 128.6, 128.6, 128.5, 128.5,
128.4, 128.4, 128.1, 100.8 (C-1’), 100.6 (C-1”), 99.5 (C-1” ’), 86.7 (C-1), 75.4
(C-4), 75.3 (C-4’), 75.1 (C-4”), 73.0 (C-3), 72.5 (C-3”), 71.9 (C-3’), 71.4 (C-2’),
71.3 (C-2”), 70.5 (C-2), 70.1 (C-2” ’), 69.6 (C-3” ’), 68.6 (C-4” ’), 65.7 (C-5), 62.4
(C-5”), 62.3 (C-5’), 60.9 (C-5” ’), 37.8 (CH2), 29.8 (CH2), 27.9 (CH3). HRMS
(MALDI) m/z calcd for C87H76O26S (M+Na+) 1591.4238, found 1591.4254.
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(42) Benzyl 2,3,4-tri-
O-benzoyl-β-D-xy-
lopyranosyl-(1→4)-
3-O-benzoyl-2-O-
levulinyl-β-D-xylopyranosyl-(1→4)-2,3-di-O-benzoyl-β-D-xylopyran-
osyl-(1→4)-2,3-di-O-benzoyl-β-D-xylopyranosyl-(1→4)-2,3-di-O-ben-
zoyl-β-D-xylopyranoside This compound was synthesized according to
General Procedure II. (toluene/heptane/ethyl acetate 3:3:2), [α]20D= – 43.0 (c
0.10, CHCl3), 1H-NMR (400 MHz, CDCl3) δ 8.00 – 7.82 (m, 20H, ArH), 7.60 –
7.47 (m, 6H, ArH), 7.46 – 7.12 (m, 29H, ArH), 5.56 (t, J = 6.7 Hz, 1H, H-3” ”),
5.54 – 5.50 (dd, J = 7.5, 8.1 Hz, 1H, H-3), 5.47 (t, J = 8.1 Hz, 1H, H- 3’), 5.39
(t, J = 8.0 Hz, 1H, H-3”), 5.29 (dd, J = 8.4, 6.6 Hz, 1H, H-2), 5.28 (t, J = 8.3
Hz, 1H, H-3” ’), 5.14 (dd, J = 8.4, 6.5 Hz, 1H, H-2’), 5.09 (dd, J = 6.9, 5.1 Hz,
1H, H-2””), 5.04 (dd, J = 8.2, 6.3 Hz, 1H, H-2”), 5.02 (m, 1H, H-4””), 4.81 (dd,
J = 8.5, 6.7 Hz, 1H, H-2” ’), 4.79 (d, J = 12.2 Hz, 1H, OCH2Ph), 4.69 (d, J =
6.3 Hz, 1H, H-1’), 4.65 (d, J = 5.0 Hz, 1H, H-1””), 4.63 (d, J = 6.7 Hz, 1H,
H-1), 4.55 (d, J = 12.3 Hz, 1H, OCH2Ph), 4.53 (d, J = 6.1 Hz, 1H, H-1”), 4.32
(d, J = 6.7 Hz, 1H, H-1” ’), 4.00 – 3.92 (m, 3H, H-4, H-5, H-5””), 3.80 – 3.63
(m, 3H, H-4’, H-4”, H-4” ’), 3.59 (dd, J = 12.2, 4.8 Hz, 1H, H-5”), 3.45 (dd, J =
12.2, 4.6 Hz, 1H, H-5” ’), 3.44 – 3.38 (m, 1H, H-5’), 3.36 (dd, J = 12.2, 8.9 Hz,
1H, H-5), 3.32 (dd, J =12.3, 6.2 Hz, 1H, H-5””), 3.19 (dd, J = 12.1, 8.4 Hz,
1H, H-5”), 3.08 (dd, J = 12.2, 8.6 Hz, 1H, H-5’), 2.99 (dd, J = 12.2, 9.0 Hz,
1H, H-5” ’), 2.60 – 2.45 (m, 2H, CH2), 2.42 – 2.28 (m, 2H, CH2), 2.05 (s, 3H,
CH3). 13C-NMR (101 MHz, CDCl3) δ 205.7 (Lev), 171.1 (Lev), 165.5 (Bz),
165.4 (Bz), 165.3 (Bz), 165.3 (Bz), 165.3 (Bz), 165.2 (2xBz), 165.0 (Bz), 164.9
(Bz), 164.9 (Bz), 136.8, 133.4, 133.4, 133.3, 133.3, 133.2, 133.1, 133.0, 133.0,
129.9, 129.9, 129.9, 129.8, 129.7, 129.7, 129.6, 129.6, 129.5, 129.5, 129.4, 129.3,
129.3, 129.2, 129.0, 128.9, 128.5, 128.5, 128.4, 128.4, 128.4, 128.3, 128.3, 128.2,
128.2, 127.8, 127.8, 101.0 (C-1’), 100.4 (C-1” ’), 100.4 (C-1”), 99.4 (C-1””), 99.3
(C-1), 76.0 (C-4), 75.2 (C-4”), 75.1 (C-4’), 74.9 (C-4” ’), 72.4 (C-3” ’), 72.1 (C-3),
72.0 (C-3’), 71.9 (C-3”), 71.4 (C-2” ’), 71.3 (C-2’), 71.1 (C-2”), 71.0 (C-2), 70.3
(OCH2Ph), 70.0 (C-2””), 69.5 (C-3””), 68.5 (C-4””), 62.6 (C-5), 62.3 (C-5” ’),
62.2 (C-5’, C- 5”), 60.7 (C-5””), 37.7(CH2), 29.6 (CH2), 27.7 (CH3). HRMS
(MALDI) m/z calcd for C107H94O33 (M+Na+) 1930.5603, found 1930.5619.
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(43) Benzyl 2,3,4-
tri-O-benzoyl-β-
D-xylopyranosyl-
(1→4)-3-O-benzo-
yl-β-D-xylopyranosyl-(1→4)-2,3-di-O-benzoyl-β-D-xylopyranosyl-
(1→4)-2,3-di-O-benzoyl-β-D-xylopyranosyl-(1→4)-2,3-di-O-benzoyl-
β-D-xylopyranoside This compound was synthesized according to General
Procedure V in 98% yield. 1H-NMR (400 MHz, CDCl3) δ 8.06 – 7.99 (m, 2H),
8.00 – 7.83 (m, 18H), 7.61 – 7.48 (m, 8H), 7.49 – 7.27 (m, 21H), 7.25 – 7.13 (m,
6H), 5.65 (t, J = 6.7 Hz, 1H, H-3” ”), 5.56-5-41 (m, 2H, H-3, H-3’), 5.41 (t, J =
8.0 Hz, 1H, H-3”), 5.33 – 5.29 (m, 1H, H-2), 5.24 – 5.14 (m, 3H, H-2””, H-3” ’,
H-2’), 5.13-5.05 (m, 2H, H-4””, H-2”), 4.80 (d, J = 12.3 Hz, 1H, -OCH2-Ph),
4.73 (d, J = 5.3 Hz, 1H, H-1””), 4.71 (d, J = 6.8 Hz, 1H, H-1’), 4.64 (d, J =
6.6 Hz, 1H, H-1), 4.55 (d, J = 12.2 Hz, 1H, O-CH2-Ph), 4.55 (d, J = 6.2 Hz,
1H, H-1”), 4.28 (d, J = 5.7 Hz, 1H), 4.28 (d, J = 5.7 Hz, 1H, H-1” ’), 4.15 (dd,
J = 12.4, 4.0 Hz, 1H, H-5” ”), 4.02 – 3.95 (m, 2H, H-4, H-5), 3.80 - 3.71 (m, 3H,
H-4””, H-4”, H-4’), 3.63 – 3.58 (m, 2H, H-5” ’, H-5”), 3.48 – 3.41 (m, 3H, H-5””,
H-2” ’, H-5”), 3.43 – 3.32 (m, 1H, H-5), 3.18 – 3.04(m, 3H, H-5” ’, H-5”, H-5’),
2.85 (d, J = 6.0 Hz, 1H, -OH). 13C-NMR (101 MHz, CDCl3) δ = 166.1 (Bz),
165.6 (Bz), 165.4 (Bz), 165.4 (Bz), 165.4 (Bz), 165.3 (Bz), 165.2 (Bz), 165.1
(Bz), 164.9 (Bz), 136.9, 133.5, 133.5, 133.4, 133.3, 133.2, 133.2, 133.0, 130.0,
130.0, 129.9, 129.9, 129.8, 129.8, 129.7, 129.6, 129.5, 129.5, 129.3, 129.2, 129.1,
128.9, 128.6, 128.5, 128.4, 128.4, 128.3, 127.9, 127.8, 101.8 (C-1” ’), 101.1 (C-1’),
100.6 (C-1”), 99.4 (C-1), 99.0 (C-1” ”), 76.1 (C-4), 75.4 (C-4’), 74.1 (C-4” ’, C-4”),
73.2 (C-3” ’), 72.3 (C-3), 72.2 (C-3’), 71.8 (C-3”), 71.5 (C-2’), 71.2 (C-2”), 71.1
(C-2” ’, C-2), 70.4 (CH2-Ph), 70.2 (C-2” ”), 69.5 (C-3” ”), 68.6 (C-4” ”), 62.7 (C-5),
62.4 (C-5’), 62.0 (C-5”), 61.3 (C-5” ’), 61.0 (C-5””). HRMS (MALDI) m/z
calcd for C102H88O31 (M+Na+) 1831.5202, found 1831.5119
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(48) Ethyl 6-O-trityl-1-thio-β-D-
glucopyranoside Ethyl 1-thio-β-D-glucopyranoside
(22.0 g, 0.0891 mol) was dissolved in 120 ml of pyridine
and trityl chloride (32.8 g, 0.118 mol) was added.
The mixture was stirred at 90 °C for 3 hours then cooled to room temperature
and diluted with ethyl acetate (300 ml). The mixture was washed with 1 M
HCl (2x300 ml) and the organic layer isolated, dried over Na2SO4, filtered and
concentrated. The crude material was purified by flash chromatography (6
heptane : 4 acetone, Rf 0.23) to yield 48 (31.8 g, 70%) as a white amorphous
solid. 1H-NMR (400 MHz, CDCl3) δ 7.44 – 7.22 (m, 15H, ArH), 4.34 (d, J =
9.6 Hz, H- 1), 3.66 – 3.48 (m, 2H, H-3, H-4), 3.41 – 3.29 (m, 4H, H-2, H-5, H-6,
H-6), 2.91 (s, 1H, OH), 2.88 (s, 1H, OH), 2.84 – 2.59 (m, 2H, SCH2CH3), 2.54
(d, J = 1.3 Hz, 1H, OH), 1.27 (t, J = 7.4 Hz, 3H, SCH2CH3). 13C-NMR (101
MHz, CDCl3) δ 143.6, 128.6, 128.0, 127.3, 85.9 (C-1), 77.8, 77.8, 72.3, 72.3, 64.7
(C-6), 24.4 (SCH2CH3), 22.8 (SCH2CH3). The data are in accordance with
literature.222
BnO O SEtBnO
OBn
HO
(50) Ethyl 2,3,4-tri-O-benzyl-1-thio-β-D-gluco-
pyranoside Triol 48 (22.6 g, 484 mmol) was dissolved
in anhydrous DMF (200 ml) and NaH (9.68 g, 242
mmol, 60% oil dispersion) was added. The reaction
mixture was cooled to 0 °C and stirred for 10 minutes. TBAI (1.25 g, 3.39 mmol)
and BnBr (28.7 ml, 242 mmol) were added slowly to the mixture. The reaction
was stirred for 16 hours at room temperature then the excess of NaH and BnBr
was quenched with methanol. The mixture was diluted with Et2O (650 ml) and
washed with water (2x400 ml). The organic phases were collected and dried over
Na2SO4, filtered and concentrated under reduced pressure. The crude product
was dissolved directly in methanol (450 ml) and concentrated H2SO4 (4.5 ml)
was added. The reaction mixture was stirred 1 hour then Na2CO3 (38.1 g) was
added to neutralize the reaction. After 2 hours the salts were filtered off and
the filtrate was diluted with dichloromethane (500 ml) and washed with water
(2x450 ml). The organic layers were combined and dried over Na2SO4. Filtration
and evaporation of the solvent under vacuum gave the crude material which was
purified by column chromatography (6 heptane : 4 acetone, Rf 0.38) to yield
50 (13.3 g, 56%). 1H-NMR (400 MHz, CDCl3) δ 7.42 – 7.21 (m, 15H, ArH),
100 Experimental Data
4.93 (d, J = 10.9 Hz, 1H, OCH2Ph), 4.92 (d, J = 10.2 Hz, 1H, OCH2Ph), 4.90 –
4.83 (m, 2H, OCH2Ph), 4.75 (d, J = 10.2 Hz, 1H, OCH2Ph), 4.66 (d, J = 10.9
Hz, 1H, OCH2Ph), 4.51 (d, J = 9.8 Hz,1H, H-1), 3.87 (dd, J = 12.0, 2.6 Hz,
1H, H-6), 3.76 – 3.65 (m, 2H, H-3, H-6), 3.58 (t, J = 9.4 Hz, 1H, H-4), 3.41 (t,
J = 9.5 Hz, 1H, H-2), 3.40 – 3.34 (m, 1H, H-5), 2.84 – 2.66 (m, 2H, SCH2CH3),
1.33 (t, J = 7.4 Hz, 3H, SCH2CH3). 13C-NMR (101 MHz, CDCl3) δ 138.4,
137.9, 128.5, 128.5, 128.4, 128.3, 128.1, 128.0, 127.9, 127.8, 127.7, 86.5 (C-3),
85.3 (C-1), 81.8 (C-2), 79.3 (C-5), 77.7 (C- 4), 75.8 (OCH2Ph), 75.6 (OCH2Ph),
75.2 (OCH2Ph), 62.2 (C-6), 25.2 (SCH2CH3), 15.2 (SCH2CH3). The data are in
accordance with the literature.209
BnO O
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OBn
HO
O
(52) Ethyl 2,3,4-tri-O-benzyl-1-thio-β-D-gluco-
pyranosiduronic acid The alcohol 50 (0.500 g, 1.01
mmol) was dissolved in a solvent mixture CH2Cl2/H2O
(2:1, 5 ml) and stirred vigorously. TEMPO (0.032 g,
0.202 mmol) and PhI(OAc)2 (0.815 g, 2.53 mmol) were
added to the mixture. Full conversion of the starting material was observed
after 50 minutes with TLC and the remaining oxidant was quenched using
Na2S2O3 (20 ml, 10% solution). The water phase was extracted with ethyl
acetate (2x20 ml), then organic layers were dried over NaSO4, filtered and the
solvent evaporated under vacuum. The carboxylic acid 52 (0.416 g, 81%) was
isolated by flash chromatography (heptane/ethyl acetate/AcOH 7:3:0.5, Rf 0.40).
1H-NMR (400 MHz, CDCl3) δ 7.40 – 7.20 (m, 15H, ArH), 4.90 (d, J = 10.3
Hz, 1H, OCH2Ph), 4.86 (d, J = 11.1 Hz, 1H, OCH2Ph), 4.81 (d, J = 11.1 Hz,
1H, OCH2Ph), 4.78 (d, J = 10.7 Hz, 1H, OCH2Ph), 4.72 (d, J = 10.3 Hz, 1H,
OCH2Ph),4.66 (d, J = 10.7 Hz, 1H, OCH2Ph), 4.59 (d, J = 9.7 Hz, 1H, H-1),
3.98 (d, J = 9.1 Hz, 1H, H-5), 3.83 (t, J = 8.9 Hz, 1H, H-4), 3.72 (t, J = 8.4 Hz,
1H, H-3), 3.49 (dd, J = 9.4, 8.3 Hz, 1H, H-2), 2.84 – 2.67 (m, 2H, SCH2CH3),
1.32 (t, J = 7.4 Hz, 3H, SCH2CH3). 13C-NMR (101 MHz, CDCl3) δ 171.4
(COOH), 138.0, 137.7, 137.3, 128.5, 128.5, 128.4, 128.3, 128.2, 128.1, 128.0, 127.9,
127.8, 85.5 (C-1), 85.0 (C-3), 81.0 (C-2), 78.6 (C-4), 77.2 (C-5), 75.6 (OCH2Ph),
75.4 (OCH2Ph), 75.0 (OCH2Ph), 25.4 (SCH2CH3), 15.0 (SCH2CH3). The data
are in accordance with literature.212
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BnO O SEtBnO
OBn
MeO
O (53) Methyl (ethyl 2,3,4-tri-O-benzyl-1-thio-β-
D-glucopyranoside) uronate Glucuronic acid 52
(0.200 g, 0.393 mmol) was dissolved in a solvent mix-
ture CH3OH/toluene (1:1, 6 ml) and a solution of
Me3SiCHN2 (0.77 ml, 2M in hexane) was slowly added to the mixture. After 3
h TLC showed full conversion of the starting material and the excess reagent
was quenched with acetic acid (2 ml). The reaction mixture was concentrated
and the crude material was purified by column chromatography (heptane/ethyl
acetate 8:2, Rf 0.36) to yield the methyl ester 53 as a white amorphous solid
(0.189 g, 92%). 1H-NMR (400 MHz, CDCl3) δ 7.44 – 6.98 (m, 15H, ArH), 4.92
(d, J = 10.2 Hz, 1H, OCH2Ph), 4.91 (d, J = 10.9 Hz, 1H, OCH2Ph), 4.85 (d,
J = 10.9 Hz, 1H, OCH2Ph), 4.78 (d, J = 10.8 Hz, 1H, OCH2Ph), 4.74 (d, J =
10.2 Hz, 1H, OCH2Ph), 4.61 (d, J = 10.8 Hz, 1H, OCH2Ph), 4.50 (d, J = 9.7
Hz, 1H, H-1), 3.89 (d, J = 9.7 Hz, 1H, H-5), 3.84 (t, J = 9.2 Hz, 1H, H-4), 3.72
(s, 3H, OCH3), 3.71 (m, 1H, H-3), 3.40 (t, J = 9.2 Hz, 1H, H-2), 2.76 – 2.59
(m, 2H, SCH2CH3), 1.24 (t, J = 7.3 Hz, 3H, SCH2CH3). 13C-NMR (101 MHz,
CDCl3) β 168.7 (C(O)-OCH3), 138.3, 137.8, 128.5, 128.4, 128.3, 128.0, 127.9,
127.9, 129.8, 127.8, 85.9 (C-1), 85.8 (C-3), 81.2 (C-2), 79.3 (C-4), 78.1 (C-5), 75.9
(OCH2Ph), 75.6 (OCH2Ph), 75.1 (OCH2Ph), 52.5 (OCH3), 25.2 (SCH2CH3),
15.0 (SCH2CH3). The data are in accordance with literature.212
O O SEtHO
OH
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(54) Ethyl 4,6-O-benzylidene-1-thio-β-D-
glucopyranoside Ethyl 1-thio-β-D-glucopyranoside
(8.26 g, 36.8 mmol) was dissolved in anhydrous
CH3CN (250 ml) together with PhCH(OMe)2 (16.6
ml, 110 mmol). CSA (4.3 g, 18.4 mmol) was added and the reaction was stirred
at 22 °C for 24 h. The mixture was neutralized with Et3N (3.6 ml, 25.8 mmol),
filtered and the solvent evaporated under reduced pressure. The crude was
purified by flash chromatography to yield 54 (4.5 g, 39%) as a white amorphous
solid. 1H-NMR (400 MHz, CDCl3) δ 7.54 – 7.44 (m, 2H, ArH), 7.42 – 7.33 (m,
3H, ArH), 5.53 (s, 1H, CHPh), 4.45 (d, J = 9.8 Hz, 1H, H-1), 4.34 (dd, J =
10.5, 4.8 Hz, 1H, H-6), 3.81 (t, J = 8.8 Hz, 1H, H-3), 3.76 (t, J = 10.1 Hz, 1H,
H-6), 3.56 (t, J = 9.2 Hz, 1H, H-4), 3.49 (t, J = 9.8 Hz, 1H, H-2), 3.52 – 3.45
(m, 1H, H-5), 2.75 (qd, J = 7.4, 2.0 Hz, 2H, SCH2CH3), 1.32 (t, J = 7.4 Hz,
3H, SCH2CH3). 13C-NMR (101 MHz, CDCl3) δ 136.9, 129.3, 128.4, 126.3,
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101.9 (CHPh), 86.6 (C-1), 80.4 (C-4), 74.6 (C-3), 73.2 (C-2), 70.6 (C-5), 68.6
(C-6), 24.8 (SCH2CH3), 15.3 (SCH2CH3). The data are in accordance with the
literature.223
O O SEtBnO
OBn
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(55) Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-
1-thio-β-D-glucopyranoside Diol 54 (4.2 g, 13.4
mmol) was dissolved in DMF (120 ml), then NaH (1.2
g, 51.6 mmol, 60% oil dispersion) was added and the
mixture was stirred at 0 °C. BnBr (4.00 ml, 33.6 mmol) was added and the
temperature was raised to room temperature. The reaction mixture was stirred
for 20 h, and the remaining NaH and BnBr were quenched with methanol (35
ml) and diluted with Et2O (200 ml). The organic phase was washed with water
(2x250 ml), dried over Na2SO4, filtered, concentrated and purified by flash
chromatography (heptane/ethyl acetate 9:1, Rf 0.24) to give 55 (4.25 g, 64%) as
a colorless oil. 1H-NMR (400 MHz, CDCl3) δ 7.52 – 7.46 (m, 2H, ArH), 7.42 –
7.27 (m, 13H, ArH), 5.59 (s, 1H, CHPh), 4.96 (d, J = 11.3 Hz, 1H, OCH2Ph),
4.89 (d, J = 10.2 Hz, 1H, OCH2Ph), 4.82 (d, J = 10.2 Hz, 1H, OCH2Ph), 4.81
(d, J = 11.3 Hz, 1H, OCH2Ph), 4.57 (d, J = 9.8 Hz, 1H, H-1), 4.36 (dd, J =
10.5, 5.0 Hz, 1H, H-6), 3.82 (dd, J = 8.2, 9.3 Hz, 1H, H-3), 3.77 (t, J = 10.5
Hz, 1H, H-6), 3.72 (t, J = 9.3 Hz, 1H, H-4), 3.47 (dd, J = 9.7, 8.2 Hz, 1H,
H-2), 3.49 – 3.40 (m, 1H, H-5), 2.85 – 2.68 (m, 2H, SCH2CH3), 1.33 (t, J = 7.4
Hz, 3H, SCH2CH3). 13C-NMR (101 MHz, CDCl3) δ 138.4, 138.0, 137.3, 129.0,
128.4, 128.3, 128.3, 128.1, 127.9, 127.7, 126.0, 101.1 (CHPh), 85.9 (C-1), 82.8
(C-3), 81.6 (C-4), 81.3 (C-2), 76.0 (OCH2Ph), 75.2 (OCH2Ph), 70.2 (C-5), 68.7
(C-6), 25.2 (SCH2CH3), 15.1 (SCH2CH3). The data are in accordance with the
literature.224
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(56) Ethyl 2,3-di-O-benzyl-1-thio-β-D-gluco-
pyranoside Acetal 55 (4.00 g, 8.12 mmol) was dis-
solved in CH2Cl2 (5 ml) and methanol (5 ml). After
addition of p-toluenesulfonic acid monohydrate (0.463
g, 2.436 mmol) the mixture was left to stirr for one hour. Afterwards the reaction
mixture was diluted with CH2Cl2 and neutralized with sodium bicarbonate. The
organic phase was separated and dried over MgSO4, filtered and concentrated.
Column chromatography (toluene : ethyl acetate, 1:5) yielded the product 56
(3.02 g, 7.47 mmol, 92% yield). 1H-NMR (400 MHz, CDCl3) δ 7.39 – 7.28 (m,
15H), 4.91 – 4.81 (m, 3H), 4.73 (d, J = 10.2 Hz, 1H), 4.48 (d, J = 9.8 Hz, 1H),
3.90 (ddd, J = 12.0, 5.8, 1.7 Hz, 1H), 3.73 (ddd, J = 11.9, 7.8, 3.7 Hz, 1H), 3.62
– 3.57 (m, 1H), 3.56 (s, 3H), 3.39 – 3.33 (m, 1H), 3.30 – 3.27 (m, 2H), 2.82 – 2.67
(m, 2H), 1.99 (dd, J = 7.8, 5.9 Hz, 1H), 1.32 (t, J = 7.4 Hz, 3H). 13C-NMR
(101 MHz, CDCl3) δ = 138.6, 138.1, 128.6, 128.5, 128.4, 128.0, 127.9, 86.4, 85.3,
81.7, 80.0, 79.4, 75.8, 75.7, 62.3, 61.0, 25.3, 15.3. The data are in accordance
with the literature.209
HO O SEtBnO
OBn
TrtO
(57) Ethyl 2,3-di-O-benzyl-6-O-trityl-1-thio-β-
D-glucopyranoside Trityl chloride (1.160 g, 4.16
mmol) was added to a solution of diol 56 (1.53 g,
3.78 mmol) in pyridine (8.22 ml) at room temperature.
After being stirred overnight at 55°C the mixture was diluted with toluene and
concentrated. Co-evaporation twice from toluene gave a crude product, which
was purified by silica gel chromatography (toluene-EtOAc 19 : 1) to yield 57
(2.177 g, 3.37 mmol, 89 % yield) 1H-NMR (400 MHz, CDCl3) β 7.40 – 7.37
(m, 6H), 7.34 – 7.31 (m, 2H), 7.28 – 7.20 (m, 14H), 7.18 – 7.14 (m, 3H), 4.85
(dd, J = 10.7, 8.0 Hz, 2H), 4.71 (dd, J = 19.2, 10.8 Hz, 2H), 4.44 (d, J = 9.4
Hz, 1H), 3.62 – 3.56 (m, 1H), 3.46 – 3.28 (m, 5H), 2.83 – 2.64 (m, 2H), 2.41 (d,
J = 2.3 Hz, 1H), 1.30 (t, J = 7.4 Hz, 3H). 13C-NMR (101 MHz, CDCl3) δ =
143.8, 128.8, 128.7, 128.6, 128.5, 128.1, 128.0, 128.0, 127.3, 87.2, 86.2, 84.9, 81.5,
78.1, 75.7, 75.6, 72.4, 64.5, 24.9, 15.4. 15.2 (SEt), 24.7 (SEt). The data are in
accordance with the literature.210
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MeO O SEtBnO
OBn
HO (58) Ethyl 2,3-di-O-benzyl-4-O-methyl-1-thio-
β-D-glucopyranoside Sodium hydride (0.579 g,
12.06 mmol), DMF (29.1 ml) was added and sub-
sequently a solution of 57 (5.2 g, 8.04 mmol)) in 2x
DMF (29.1 ml) dropwise at 0°C. After 1 h, a solution of methyl iodide (0.704 ml,
11.25 mmol) in DMF (29.1 ml) was added and the solution was allowed to attain
room temperature. After 3 h, MeOH (5 ml) was carefully added and the mixture
was diluted with toluene, washed three times with water, dried, and concentrated
in vacuo. The residue was dissolved in CHCl3- MeOH (2:1; 150 ml) and the
pH was adjusted to 2 by addition of p-toluenesulfonic acid (PTSA). After 2h,
the mixture was washed successively with water and saturated aq. NaHCO3,
dried, concentrated, and purified on a silica gel column (toluene-EtOAc 6 : 1)
to give 58 (2.27 g, 5.42 mmol, 68% yield) 1H-NMR (400 MHz, CDCl3) δ 7.39
– 7.27 (m, 10H), 4.91 – 4.82 (m, 3H), 4.73 (d, J = 10.2 Hz, 1H), 4.48 (d, J =
9.8 Hz, 1H), 3.90 (ddd, J = 12.0, 5.8, 1.7 Hz, 1H), 3.73 (ddd, J = 11.9, 7.8, 3.7
Hz, 1H), 3.62 – 3.57 (m, 1H), 3.56 (s, 3H), 3.38 – 3.33 (m, 1H), 3.32 – 3.25 (m,
2H), 2.84 – 2.66 (m, 2H), 1.99 (dd, J = 7.8, 5.9 Hz, 1H), 1.32 (t, J = 7.4 Hz,
3H). 13C-NMR (101 MHz, CDCl3) δ = 138.6, 138.1, 128.6, 128.5, 128.4, 128.0,
127.9, 86.4, 85.3, 81.7, 80.0, 79.4, 75.8, 75.7, 62.3, 61.0, 25.3, 15.3. The data are
in accordance with the literature.210
MeO O SEtBnO
OBn
HO
O
(59) Ethyl 2,3-di-O-benzyl-4-O-methyl-1-thio-
β-D-glucopyranosiduronic acid
To a vigorously stirred solution of alcohol 58 (2.49
g, 5.95 mmol) in 17 ml CH2Cl2 and 8.5 ml H2O was
added TEMPO (0.186 g, 1.190 mmol) and phenyl-
I3-iodanediyl diacetate (4.79 g, 14.87 mmol). Stirring was allowed until TLC
indicated complete conversion of the starting material to a lower running spot
(approx. 45 min). The reaction mixture was quenched by the addition of 10 ml
Na2S2O3 solution (10% in H2O). The mixture was then extracted twice with
EtOAc (10 ml) and the combined organic layers were dried (MgSO4), filtered and
concentrated. Flash column chromatography using 5 ethyl acetate : 5 heptane +
1% AcOH afforded the pure glycuronic acid 59 (1.886 g, 4.36 mmol, 73% yield)
1H-NMR (400 MHz, CDCl3) δ 7.38 – 7.27 (m, 10H), 4.87 (d, J = 10.4 Hz, 1H,
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BnO-2), 4.82 (d, J = 11.0 Hz, 1H, BnO-3), 4.78 (d, J = 11.0 Hz, 1H, BnO-3),
4.70 (d, J = 10.4 Hz, 1H, BnO-2), 4.57 (d, J = 9.7 Hz, 1H, H-1), 3.91 (d, J =
8.9 Hz, 1H, H-5), 3.64 (t, J = 8.2 Hz, 1H, H-3), 3.55 (s, 3H), 3.60 – 3.50 (m, 1H,
H-4), 3.43 (dd, J = 9.6, 7.9 Hz, 1H, H-2), 2.83 – 2.68 (m, 2H), 1.32 (t, J = 7.4
Hz, 3H). 13C-NMR (101 MHz, CDCl3) δ = 170.6 (COOH), 138.1, 137.8, 128.6,
128.6, 128.4, 128.1, 128.0, 128.0, 85.5 (C-1), 84.9 (C-3), 80.8 (C-2, C-4), 76.9
(C-5), 75.6 (BnO-2), 75.5 (BnO-3), 60.8 (OMe), 25.5 (SCH2), 15.2 (SCH2CH 3).
MeO O SEtBnO
OBn
MeO
O
(60) Methyl (ethyl 2,3-di-O-benzyl-4-O-
methyl-1-thio-β-D-glucopyranosid)uronate
To a solution of acid 59 (1.886 g, 4.36 mmol) in
toluene (14.75 ml) and methanol (4.21 ml) was added
trimethylsilyldiazomethane (2.83 ml, 5.67 mmol). Af-
ter 20 minutes of stirring at room temperature more trimethylsilyldiazomethane
was added (0.5 eq). After 10 more minutes the mixture was concentrated to
yield the methyl ester 60 (1.947 g, 4.36 mmol, 100% yield). The analytical data
are in accordance with the literature.210 1H-NMR (400 MHz, CDCl3) δ 7.31 –
7.20 (m, 10H), 4.82 (d, J = 10.2 Hz, 1H), 4.80 (d, J = 10.2 Hz, 1H), 4.76 (d,
J = 11.0 Hz, 1H), 4.65 (d, J = 10.2 Hz, 1H), 4.41 (d, J = 9.7 Hz, 1H), 3.74 (s,
3H), 3.71 (d, J = 9.3 Hz, 1H), 3.57 – 3.43 (m, 2H), 3.43 (s, 3H), 3.35 (dd, J =
9.5, 8.6 Hz, 1H), 2.76 – 2.59 (m, 2H), 1.23 (t, J = 7.4 Hz, 3H). 13C-NMR (101
MHz, CDCl3) δ 168.9, 138.4, 138.0, 128.6, 128.5, 128.4, 128.0, 128.0, 127.9, 85.9,
85.8, 81.3, 81.1, 78.1, 75.9, 75.7, 60.8, 52.7, 25.3, 15.1.
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AB
CD
E
F
G
O
OBz
BzO
BzO O
OBz
O
O O
OBz
O
O O
OBz
O
O SPh
OBz
OBz
O
BzO
OBz
OBz
O
BzO
OBz
OBz
O
BzO
(61) Phenyl 2,3,4-Tri-O-
benzoyl-β-D-xylopyran-
osyl-(1→4)-[2,3,5-tri-O-
benzoyl-α-L-arabinofu-
ranosyl-(1→3)]-2-O-ben-
zoyl-β-D-xylopyranosyl-
(1→4)-[2,3,5-tri-O-benzo-
yl-α-L-arabinofuranosyl-
(1→3)]-2-O-benzoyl-β-D-xylopyranosyl-(1→4)-[2,3,5-tri-O-benzoyl-α-
L-arabinofuranosyl-(1→3)]-2-O-benzoyl-1-thio-β-D-xylopyranoside A
mixture of the triol 38 (102 mg, 0.081 mmol) and acetimidate 68 (169 mg,
0.266 mmol) was co-evaporated with toluene (2 × 20 ml) and subjected to
high vacuum for 2 h. The mixture was dissolved in anhydrous CH2Cl2 (20
ml) and cooled to -40 °C. TMSOTf (1.459 µl, 8.07 µmol) was added and the
reaction mixture was stirred at -40 °C until TLC (toluene/EtOAc 20:1) showed
completion of the reaction (10-30 min). The reaction mixture was quenched by
addition of triethylamine (7.88 µl, 0.057 mmol) evaporated and purified by flash
column chromatography (9.6 Toluene/0.4 Acetone, Rf = 0.13), 1H-NMR (400
MHz, CDCl3) δ 8.18 (d, J = 7.2 Hz, 2H), 8.11 – 7.87 (m, 25H), 7.65 – 7.41 (m,
28H), 7.37 – 7.16 (m, 25H), 5.72 (t, J = 9.3 Hz, 1H, D-3), 5.52 (d, J = 5.6 Hz,
1H), 5.49 (d, J = 5.4 Hz, 1H), 5.45 (d, J = 4.5 Hz, 1H), 5.43 (d, J = 0.6 Hz,
1H), 5.37 (d, J = 1.0 Hz, 1H), 5.35 (d, J = 1.4 Hz, 1H), 5.34 (bs, 1H, E-1), 5.30
– 5.26 (m, 2H, A-2, D-2), 5.29 (bs, 1H, F-1), 5.24 (bs, 1H, G-1), 5.16 (td, J =
9.3, 5.5 Hz, 1H), 5.07-4.68 (m, 11H, B-2, E-5, F-5, G-5), 4.68 (d, J = 8.8 Hz,
1H, A-1), 4.22 (d, J = 8.0 Hz, 1H, B-1), 4.11 (d, J = 7.4 Hz, 1H, D-1), 4.08 –
3.99 (m, 2H, A-3, A-5), 3.88 – 3.82 (m, 3H, A-3, D-5), 3.76 (td, J = 8.8, 4.8
Hz, 1H, A-4), 3.33 (dd, J = 11.8, 5.1 Hz, 1H, C-5), 3.29 – 3.23 (m, 1H, B-4),
3.22 (dd, J = 11.8, 9.8 Hz, 1H, D-5), 3.10 – 3.02 (m, 2H, A-5, B-5), 2.67 – 2.61
(m, 2H, C-5), 2.61 – 2.56 (m, 2H, B-5). 13C-NMR (101 MHz, CDCl3) δ 166.4
(Bz), 166.4 (Bz), 166.1 (Bz), 165.9 (Bz), 165.8 (Bz), 165.7 (Bz), 165.1 (Bz),
165.1 (Bz), 165.0 (Bz), 164.7 (Bz), 164.4 (Bz), 164.2 (Bz), 133.9, 133.7, 133.5,
133.4, 133.3, 133.2, 133.2, 133.0, 132.9, 132.5, 130.4, 130.2, 130.1, 130.1, 130.1,
129.9, 129.9, 129.9, 129.8, 129.8, 129.7, 129.7, 129.6, 129.5, 129.3, 129.2, 129.2,
129.1, 129.1, 129.0, 129.0, 129.0, 128.9, 128.6, 128.5, 128.5, 128.5, 128.4, 128.4,
128.3, 128.3, 128.2, 127.9, 125.4, 106.1 (CH, F-1), 105.7 (CH, G-1), 105.6 (CH,
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E-1), 100.3 (CH, B-1), 100.0 (CH, C-1), 99.8 (CH, D-1), 86.7 (C1), 82.8 (CH),
82.7 (CH), 82.5 (CH), 82.1 (CH), 81.5 (CH), 80.8 (CH), 78.3 (CH), 78.2(2xCH),
76.0(CH, A-3), 75.3(CH, C-3), 75.2(CH, B-3), 74.5 (CH, E-4), 74.2 (CH, B-4),
73.7 (CH, A-4), 73.3 (CH, D-2), 73.0 (CH, E-2), 72.2 (CH, A-2), 72.0 (CH,
D-3), 71.2 (CH, D-2), 69.8 (CH, D-4), 66.0(CH2, A-5), 64.0(CH2), 63.9(CH2),
63.8(CH2), 63.1(CH2), 63.04(CH2), 62.96 (CH2, D-5). HRMS (MALDI) m/z
calcd for C146H122O43S (M+Na+) 2617.6973, found 2618.6839.
O
OBz
BzO
BzO O
OBz
O
O O
OBz
O
O O
OBz
O
O
OH
OBz
OBz
O
BzO
OBz
OBz
O
BzO
OBz
OBz
O
BzO
(62) 2,3,4-Tri-O-benzo-
yl-β-D-xylopyranosyl-
(1→4)-[2,3,5-tri-O-ben-
zoyl-α-L-arabinofurano-
syl-(1→3)]-2-O-benzo-
yl-β-D-xylopyranosyl-
(1→4)-[2,3,5-tri-O-ben-
zoyl-α-L-arabinofurano-
syl-(1→3)]-2-O-benzoyl-β-D-xylopyranosyl-(1→4)-[2,3,5-tri-O-ben-
zoyl-α-L-arabinofuranosyl-(1→3)]-2-O-benzoyl-D-xylopyranoside
N-bromosuccinimide (41.7 mg, 0.234 mmol) was added at room temperature to
a stirred solution of the phenyl thioglycoside 61 (1 equiv) in 9: 1 acetone-water
(1.75 ml). Stirring was continued for a period of 60 minutes. The solvent
was evaporated at room temperature until turbidity arose. The residue was
dissolved in ethyl acetate washed three times with a saturated aqueous solution
of sodium hydrogen carbonate, three times with water, dried over anhydrous
sodium sulfate and the solvent evaporated. The product was isolated by column
chromatography on silica gel (4 acetone : 6 heptane).130 HRMS (MALDI)
m/z calcd for C140H118O44 (M+Na+) 2525.6888, found 2525.6699.
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O
OH
HO
HO O
OH
O
O O
OH
O
O O
OH
O
O
OH
OH
OH
O
HO
OH
OH
O
HO
OH
OH
O
HO
(63) β-D-xylopyranosyl-
(1→4)-[α-L-arabinofura-
nosyl-(1→3)]-β-D-xylopy-
ranosyl-(1→4)-[α-L-ara-
binofuranosyl-(1→3)]β-
D-xylopyranosyl-(1→4)-
[α-L-arabinofuranosyl-
(1→3)]-D-xylopyranoside Heptasaccharide 62 (50 mg, 0.020 mmol) was
dissolved in 1 ml MeOH and 2 ml CH2Cl2. After addition of 1 equivalent of
sodium methoxide the solution was left to stirr for 45h. The solution was
neutralized with Amberlite IR120 H+, the resin filtered off and the solvent
evaporated. Purification has so far not been successful, but HRMS detection
confirmed the existence of the product. HRMS (MALDI) m/z calcd for
C35H58O29 (M+Na+) 965.2956, found 965.2953
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OO
BzO
O
O
O
OBz
BzO
BzO O
O
OBz
BzO O
OBz
OBzO O OBn
OBz
BzO
OMe
O
OBn
OBn
MeO
O
(64) Benzyl 2,3,4-Tri-
O-benzoyl-β-D-xylopy-
ranosyl-(1→4)-[methyl
2,3,-O-benzyl-4-O-me-
thyl-(α/β)-glucuronatyl-
(1→2)]-3-O-benzoyl-β-D-
xylopyranosyl-(1→4)-2,3-
O-benzoyl-β-D-xylopyranosyl-(1→4)-2,3-O-benzoyl-β-D-xylopyran-
osyl-(1→4)-2,3-O-benzoyl-β-D-xylopyranoside The donor 60 (100 mg,
0.224 mmol) was dissolved in 1 ml CH2Cl2. A dry solution of 0.4M bromine in
CH2Cl2 was added (0.28 ml, 0.11 mml). The conversion cannot be observed
by TLC. Within one hour 4 equivalents of bromine were added. Afterwards,
the solution is washed with sodium thiosulfate, dried and evaporated. The
crude product was redissolved in toluene, mixed with 0.67 equivalents of the
pentasaccharide acceptor 43 (270 mg, 0.149 mmol) and evaporated to dryness.
The dry mixture is redissolved in 1 ml CH2Cl2 and not more than 0.1 ml
diethyl ether. 100 mg of powdered molecular sieves are added and the mixture
is cooled down to -30°C. Silver(I) perchlorate (55.7 mg, 0.269 mmol) is added
to the solution and the mixture is stirred for 60 minutes. The mixture was
quencehed with 0.04 ml of triethyl amine and purified. Column chromatography
(3 acetone / 7 pentane) yielded 15% of the acceptor and an inseparable mixture
of both anomers of 64 (209 mg, 0.095 mmol, 64% yield, 75% b.r.s.m.). HRMS
(MALDI) m/z calcd for C124H112O37 (M+Na+) 2215.6775, found 2215.6660
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HO
O
O
O
OH
HO
HO O
O
OH
HO O
OH
OHO O OBn
OH
HO
OMe
O
OBn
OBn
MeO
O
(66) Benzyl β-D-
xylopyranosyl-(1→4)-
[methyl 2,3-O-benzyl-
4-O-methyl-(α/β-
glucuronatyl-(1→2)]-β-D-
xylopyranosyl-(1→4)-β-
D-xylopyranosyl-(1→4)-
β-D-xylopyranosyl-(1→4)-β-D-xylopyranoside 150 mg of a mixture of
both anomers of 64 were dissolved in 10 ml of CH2Cl2 / MeOH (1:1) and 1
equivalent of sodium methoxide was added. The solution was stirred over 48
hours after which it was neutralized with Amberlite IR120 H+. The resin was
filtered off and the solvent evaporated. While purification by HPLC has so
far not been successful, the existence of the product was confirmed by HRMS.
HRMS (ESI) m/z calcd for C54H72O27 (M+Na+) 1175.4153, found 1175.4166
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